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Obesity and obesity-related diseases such as type-2 diabetes or metabolic syndrome are on the rise word-
wide (Ng et al. 2014). The negative aspects of obesity on the health of individuals is accompanied by an 
increasing financial burden for the global economy.  Excess adipose tissue is often perceived as an 
indication of poor dietary choices and a sedentary lifestyle. However, compelling evidence from diverse 
model organisms and humans suggest that genetic make-up influences most aspects of fat metabolism 
and therefore the likelihood to develop obesity (Min, Chiu, and Wang 2013; Yazdi, Clee, and Meyre 2015). 
Hence, careful dissection of the underlying genetic regulations of fat metabolism to identify new putative 
targets for treatment is essential. 
We successfully used Caenorhabditis elegans as a model organism to uncover and describe a novel auto-
regulatory module, which we found is essential for wild-type levels of body fat. Utilizing cold-sensitivity 
as readout, we identified a hitherto uncharacterized gene, C30F12.1, which we named rege-1 (REGnasE-
1 homolog) after its mammalian homolog the PIN-domain endonuclease ZC3H12A/Regnase-1/MCPIP1. 
Regnase-1 negatively regulates pro-inflammatory cytokines via internal cleavage of their 3` untranslated 
region (3`UTR) (Iwasaki et al. 2011; Matsushita et al. 2009). Similarly, C. elegans REGE-1 targets the 
transcription factor ETS-4 and cleaves its mRNA within the first third of its 3`UTR. Knockout of rege-1 
causes a strong loss in overall body fat, developmental delay and a transcriptional upregulation of fat 
metabolic and innate immunity genes, depending on ETS-4. We also provide evidence that ETS-4 
transcriptionally activates (directly or indirectly) rege-1, thereby forming an auto-regulatory feedback 
loop. REGE-1::GFP is mainly localized in the first four cells of the intestine adjacent to the pharynx and the 
ETS-4/REGE-1 module is transcriptionally upregulated upon re-feeding following long-term starvation. 
This, together with the observation that metabolic and immunity genes are induced upon loss of rege-1 
suggests that the ETS-4/REGE-1 module might have a role in bacteria clearance, nutrient uptake and/or 




1.1 Fat metabolism in Caenorhabditis elegans 
Fat, carbohydrate and protein comprise the three macro nutrients essential to life. Fats are esters of a 
glycerol and three fatty acids (=triglyceride) and belong to the class of lipids. They are either stored, 
utilized for energy production or can serve structural and signaling purposes. In addition, dietary fats are 
essential for the uptake of fat-soluble vitamins such as vitamin A. Therefore, precise regulation of 
breakdown, storage and modification of lipids, together with their de-novo synthesis, known as fat 
metabolism, is indispensable for every organism. In mammals, fat is stored in designated adipose tissue 
that can be roughly subdivided into brown, white and beige fat. In contrast, the main metabolic tissue in 
C. elegans is the gut, in which the vast majority of fat is stored and processed (Srinivasan 2015; Watts 
2009). Additionally, fat deposits are visible in the oocytes and the hypodermis (Chen et al. 2016; O'Rourke 
et al. 2009; Schneider 1996; Zhang, Trimble, et al. 2010). Although H. sapiens and C. elegans are separated 
by more than 600 million years of evolution (Ruvkun and Hobert 1998), many aspects of fat metabolism 
are shared and C. elegans has proven to be an excellent model organism to study the genetic influence 
on body fat (Lemieux and Ashrafi 2015; Zheng and Greenway 2012). Among the general advantages of 
this model organism are a short life cycle of about three days, high number of progeny (approximately 
250 per animal) with negligible genetic variation, a transparent body, small size and low culture expenses. 
Its transparent body makes it fairly easy to study the influence of genetic mutations and chemical 
compounds on the distribution and quantity of fat. Lipophilic dyes, fluorescently labeled fatty acids (e.g. 
BODIPY), GFP-tagged proteins or staining-free methods can be used to visualize C. elegans fat stores. The 
most commonly utilized dyes are Oil red O, Sudan black and Nile red (Yen et al. 2010). The lipophilic dye 
Oil red O stains neutral lipids and was recently established in 96-well plate format, which makes it feasible 
to perform large-scale library screens of either chemical compounds or RNAi-knockdowns (Wahlby et al. 
2014).  The obvious downside of these dye-based methods is that they are unsuitable for live imaging as 
they require fixation of the specimen. To overcome this issue, different GFP tagged proteins which co-
localize with lipid droplets (LDs) are used for live imaging of fat stores. DHS-3 was identified in a mass 
spectrometry analysis of LD resident proteins (Zhang et al. 2012). Consistently, DHS-3::GFP localizes to 
LDs, forming ring structures and can be used as a read out for number and size of these fat compartments 
(Zhang et al. 2012). Perilipin 1 (PLIN-1) is a lipid-droplet associated protein naturally not present in C. 
elegans, however when expressed in these animals it localizes to LDs and was successfully used to identify 
known and novel lipid associated proteins by extraction of LDs and follow-up mass-spectrometry (Liu et 
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al. 2014). Coherent anti-strokes raman scattering (CARS) microscopy is a staining-free method that uses 
the physical properties of fat to assess stores in living C. elegans (Hellerer et al. 2007; Tserevelakis et al. 
2014). Another advantage of the C. elegans model system is that small chemicals such as fatty acids or 
pharmacological compounds can be conveniently administered by feeding. For example mutations in fat-
3, an enzyme that catalyzes the rate limiting step in polyunsaturated fatty acid (PUFA) production, can be 
rescued by  dietary supplementation of the missing PUFAs (Watts et al. 2003). Likewise exogenous 
serotonin mitigates neurological defects of loss of TPH-1, the enzyme that catalyzes the rate-limiting step 
in serotonin synthesis (Li et al. 2013). Biochemical assays can be limited due to the rigid cuticle and the 
fact that a whole animal lysis contains a mixture of different tissues. However, many tools for metabolic 
research have been adjusted to nematodes. Among the most important are: 1. whole lipid analysis 
(summarized in (Witting and Schmitt-Kopplin 2016)) 2. the extracellular flux technology, marketed by 
Seahorse, with which oxygen consumption and glycolysis can be measured (Koopman et al. 2016; Luz et 
al. 2015), and 3. whole animal metabolomics reviewed in (von Reuss and Schroeder 2015).  
 
Figure 1:  Schematic of a C. elegans body plan (A) and the pharynx (B). 
1.1.1 Absorption of nutrients 
The intestine of C. elegans is one of the largest tissues (Figure 1A) of the animal and fulfils a variety of 
tasks which are performed by distinct organs in higher organisms: digestion; synthesis and storage of 
macro and micro nutrients; defense against pathogens and, during adulthood, it provides the developing 
oocytes and embryos with nutrients. The intestine consists of 20 polyploid epithelia cells which are 
arranged in pairs and form a tube that reaches from the end of the pharynx-intestinal valve through the 
whole animal. C. elegans feed by contracting and relaxing the pharyngeal muscle, which can be subdivided 
into: procorpus, metacorpus, isthmus and posterior bulb/grinder (Figure 1B). At the beginning of one 
contraction/relation cycle the lumen of the corpus and the anterior isthmus are opened by contraction 
and bacterial suspension is sucked in, while at the same time contraction of the posterior bulb leads to 
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grinding of already trapped bacteria. During the relaxation state, liquid is expelled from the corpus into 
the environment while fresh bacteria are trapped and the crushed bacteria in the posterior bulb released 
into the pharyngeal-intestinal valve from where they enter the intestine (Avery and Shtonda 2003; Fang-
Yen, Avery, and Samuel 2009).  The crushing of bacteria serves a dual purpose: Firstly, to avoid any live 
bacteria entering the gut, thereby reducing the risk of infection and, secondly, to release nutrients. The 
lumen of the intestine, similar to the stomach in higher organisms, is slightly acidic (Chauhan et al. 2013), 
which facilitates digestion of macromolecules and provides a suitable environment for digestive enzymes. 
In addition, a whole range of different lysosomal enzymes, proteases and lipases are expressed by the 
intestinal cells and partially released into the lumen (McGhee et al. 2007) to facilitate digestion of bacterial 
content. Subsequently, nutrients have to pass through the intestinal cells membrane, either passively (e.g. 
free fatty acids) or are actively transported across the membrane. Di- and tri-peptides are taken up with 
the help of the high capacity/low affinity peptide transporter PEPT-1, which transports a wide range of up 
to 8000 different peptides (Spanier et al. 2009). Its functionality depends on the proton transporter NHX-
1, which increases intestinal cell pH (Nehrke 2003). Loss of pept-1 increases overall fat of the animals, 
which is likely facilitated by an accelerated absorption of free fatty acids from the intestine (Spanier et al. 
2009). The transport of fatty acids across the membrane of intestinal cells might be facilitated by ACS-20 
and ACS-22, both orthologs of the mammalian fatty acid transport protein 1 (FATP1) and FATP4. By 
homology, ACS-20 and ACS-22 likely serve dual functions: as Acetyl-CoA synthetases of very long fatty 
acids (ACSVL) and as fatty acid transporters. The role of ACS-20 and ACS-22 as ACSVL was confirmed 
recently and it was shown that human FATP4 can rescue acs-20;acs-22 mutant phenotype, indicating high 
functional conservation of these proteins (Kage-Nakadai et al. 2010). ACS-22 is part of the TAG synthesis 
complex, is important for expansion of lipid droplets in daf-22 (DAF-22 is a peroxisome-specific thiolase) 
mutants (Li, Xu, et al. 2016) and is required for iron-induced lipid uptake (Wang et al. 2016). Thus, although 
acs-20 and acs-22 seem to be the only homologs of mammalian FATP (Dourlen et al. 2015; Kage-Nakadai 
et al. 2010), whether they really function as sole fatty acid transporters in C. elegans needs further 
investigation. Glucose transport is mediated by GLUT transporters in mammals. The C. elegans genome 
encodes eight genes with homologies to these mammalian proteins, however, only fgt-1 (facilitated 
glucose transporter, isoform 1), localized in the basolateral membrane of intestinal cells seems to encode 
for a functional glucose transporter (Feng et al. 2013; Kitaoka, Morielli, and Zhao 2013). Loss of fgt-1 leads 
to decreased glucose transport, reduced glucose metabolism and prolonged life span (Feng et al. 2013). 
The life span extension seen in the insulin/insulin-like signaling-defective daf-2 mutants seems to partially 
depend on reduced FGT-1 glucose transport function observed in these mutants (Feng et al. 2013; Kitaoka, 
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Morielli, and Zhao 2016). In addition, like daf-2 mutants, fgt-1 mutants exhibit increased overall fat in the 
intestine (Kitaoka, Morielli, and Zhao 2013).  
1.1.2 Lipid composition and fat accumulation 
Triglycerides are the main form of stored fats in C. elegans and make up about 45% of the total fat content 
(Brock, Browse, and Watts 2006). In addition, but much less prominent, mono- and di-glycerides are  
found (Srinivasan 2015). Natural triglycerides are composed of an ester of glycerol and three fatty acid 
chains of varying length with an even number of carbon atoms. Fatty acids can be mono- or 
polyunsaturated and a sophisticated network of elongases (ELOs) and fatty acid desaturases (FATs) 
increase the complexity of the lipid composition (Kniazeva et al. 2003; Watts and Browse 2002). The ratio 
of mono-unsaturated fatty acids (MUFAs) and poly-unsaturated fatty acids (PUFAs) depend on species of 
bacteria in the diet as well as ambient temperature (Brooks, Liang, and Watts 2009; Tanaka et al. 1996). 
Misbalance can have severe consequences on the animals` physiology and behavior. The phenotypes 
range from neurological defects to developmental delay and, in case of total loss of PUFAs as seen in the 
fat-5/fat-6/fat-7 triple mutants, to embryonic lethality (Kniazeva et al. 2003; Lesa et al. 2003; Watts et al. 
2003). Very recently it was shown that an increase in MUFA, but not PUFA, seen in mutants of the 
H3K4me3 modifier, can extend the animals’ lifespan (Han et al. 2017). In addition to triglycerides, the 
second major class of lipids present in C. elegans are phospholipids. This pool of lipids is mainly found in 
cellular membranes and comprises: 54.5% ethanolamine glycerophospholipid (EGP), 32.3% choline 
glycerophospholipid (CGP), 8.1% sphingomyelin and 5.1% others (Satouchi et al. 1993).  
As C. elegans lacks specialized organs for catabolic and anabolic fat metabolism, digestion of dietary fats; 
fat synthesis and fat storage need to be spatially and temporally coordinated within the same gut cells. 
This can either be accomplished by high compartmentalization or temporal restriction of, for example, 
lipase expression. In the gut, most fat is stored in specialized lipid droplets (LDs) ranging from 50 nm to 
3000 nm (Zhang et al. 2012), that are surrounded by a monolayer of phospholipids and are filled with 
neutral lipids such as triglycerides (Zhang, Box, et al. 2010). LDs are derived from the endoplasmic 
reticulum and expand depending on the need for fat storage (Zhang, Box, et al. 2010). The expansion of 
LD is accomplished by acetyl CoA synthase-22 and diacylglycerol acyl transferase-2, the C. elegans 
homologs of FATP1 and DGAT2, respectivley (Xu, Zhang, et al. 2012). These two well-conserved proteins 
co-localize on ER and LD membranes and a loss of either FATP1 or DGAT2 function blocks LD expansion. 
When LDs are filled with sufficient triglycerides, the lipid droplets bud off from the ER. This is facilitated 
by FIT (fat storage inducing transmembrane) proteins; the homolog in C. elegans is encoded by fitm-2 and 
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its loss causes reduced LD size accompanied by muscular defects and high lethality (Choudhary et al. 
2015). The final step of LD budding, fusion of the ER membrane to release the droplet, is aided by the 
GFPase atlastin (ATLN-1) (Klemm et al. 2013). Lysosome related organelles (LROs; also termed gut 
granules) which are compartments similar to lysosomes and peroxisomes contain neutral lipids, but do 
not represent a major site of fat storage in C. elegans (O'Rourke et al. 2009). As the amount of live Nile 
red staining (which marks LROs) increases upon fasting, LROs where suggested to be the site of initial lipid 
beak down (O'Rourke et al. 2009). In addition to the gut, fat staining can also be seen in the hypodermis. 
However, whether the hypodermis is a classical fat storage organ or if fat droplets are stored for local 
energy production is uncertain.  
In order to ensure sufficient energy supply for the next generation, lipids and other nutrients from the gut 
are packed into yolk particles, secreted into the pseudocoelomic space and taken up by the oocytes via 
receptor-mediated endocytosis (Kimble and Sharrock 1983; Schneider 1996; Sharrock et al. 1990). This is 
accomplished by the vitellogenin (yolk proteins) proteins VIT-2, VIT-3, VIT-4,VIT-5 and VIT-6 (Spieth et al. 
1991), which are distantly related to the mammalian lipid transport protein ApoB-100 (Smolenaars et al. 
2007). As this process places a high burden on the animal, it is tightly transcriptionally and post-
transcriptionally controlled (DePina et al. 2011; Goszczynski et al. 2016). In the long-lived mutant daf-2, 
vit-2 expression is strongly decreased and thereby energy is conserved (Goszczynski et al. 2016; 
Mendenhall et al. 2017). 
1.1.3 Lipid degradation  
The lipase-mediated hydrolysis of dietary triglycerides (TAGs) into glycerol and free fatty acids (FAs) serves 
two major purposes: Firstly, free FAs are available as building blocks to form membrane lipids, lipid-based 
signaling molecules and triglycerides for storage and secondly, FAs can be degraded via β-oxidation in 
peroxisomes and mitochondria to provide energy. Most lipases are expressed in the intestinal cells and 
are either secreted into the gut lumen or retained within the cell to facilitate degradation of dietary lipids 
and stored lipids, respectively. The C. elegans genome encodes a variety of lipases, many of which have 
been investigated with respect to starvation; examples include the fasting induced lipases (fil-1/2), lipl-1-
7 (Lipase like) or the adipose triglyceride lipase atgl-1. Their regulation will be discussed in detail in the 
chapter “1.1.5 Regulation of fat metabolism and alteration during different physiological conditions”. 
After hydrolysis of TAGs, FAs are transported to either mitochondria or peroxisomes, depending on their 
length. Understanding of these transport mechanisms is incomplete and therefore conclusions about the 
involvement of certain genes in this process can only be made via study of their homologs in the 
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mammalian system. Putative fatty acid binding proteins (FABPs) are encoded by lbp-1-9 and EEED8.3 
(Mullaney and Ashrafi 2009). All but lbp-4 and lbp-8 contain a secretion signal. lbp-1, lpd-2 and lpd-3 were 
shown to be localized in the perivitellin space  (a liquid filled clear zone between the embryo and the 
eggshell) and in the body wall muscles after hatching (Plenefisch et al. 2000). A clear connection between 
a C. elegans FABP homolog and fat metabolism was made with studies of LBP-5, which is expessed in 
various tissues including the intestine and the hypodermis and binds fatty acids in vitro (Xu, Joo, and Paik 
2011). Loss of lbp-5 leads to reduced ATP and lactate levels as well as a reduced abundance of 
mitochondrial and β-oxidation proteins (Xu, Choi, and Paik 2014). The mammalian CD36 (cluster of 
differentiation 36) is an integral membrane protein that binds a diverse class of ligands including long-
chain fatty acids (Baillie, Coburn, and Abumrad 1996; El-Yassimi et al. 2008). Circulating fatty acids serve 
as metabolic signal that is sensed by CD36 in the brain and loss of neuronal CD36 increases feeding, body 
weight, and fat mass in rats (Le Foll et al. 2013; Le Foll, Dunn-Meynell, and Levin 2015; Moulle et al. 2013). 
C. elegans encodes six SCAVenger receptor (CD36 family) related proteins: scav-1-6. So far only scav-3 
was studied more closely and was found to be involved in maintenance of lysosome integrity and longevity 
(Li, Chen, et al. 2016). Thus, it remains to be shown whether this class of proteins has a direct role in C. 
elegans fat metabolism. Long, medium and small chain fatty acids are oxidized in the mitochondria, 
whereas very long fatty acids (22 or more carbons) are exclusively oxidized in the peroxisomes. FAs can 
enter the mitochondria only as acyl carnitines, which are generated by the CPT I (carnitine palmotoyl 
transferase) complex. They are then transported through the outer and inner mitochondria membrane by 
translocases and the carnitine is removed by the CPT II complex, making the FA available for β-oxidation. 
Each round of oxidation reduces the fatty acid chain by two carbon atoms, producing Acetyl-coA, which 
is then used to generate energy in form of ATP via the Krebs cycle. A simplified overview of fat synthesis 
and β-oxidation pathways with indicated putative C. elegans homologs for the respective mammalian 





Figure 2: Schematic overview of the fat synthesis and degradation pathways.  
Gene Ontology annotations from WormBase version WS258 (http://www.wormbase.org) were used to 
assign C. elegans homologs (in green) to the mammalian enzymes (in blue). Figure 3 of the review 
“Regulation of body fat in Caenorhabditis elegans” was used as basis for the graphic design (Srinivasan 
2015). Abbreviations: ACS...acetyl CoA synthase, CPT-1/2...carnitine palmotoyl transferase, DH… 
dehydrogenase, 3-HACD...3-hydroxy acetyl CoA dehydrogenase, FFA...free fatty acid, (V)LCFA...(very) long 





1.1.4 Signaling pathways regulating lipid metabolism  










Figure 3: Insulin signaling pathway in fat metabolism: Activation of 
DAF-2 by an insulin-like peptide leads to the activation of a down-
stream cascade, which ultimately causes DAF-16 inactivation by 
phosphorylation. See text for details. 
 
The insulin-signaling-pathway is well-known for its influence on longevity; loss of function mutations in 
daf-2, the receptor for insulin, double the lifespan of C. elegans (Kenyon et al. 1993; Kenyon 2010). The 
signaling cascade downstream of DAF-2 is reviewed in (Altintas, Park, and Lee 2016; Murphy and Hu 2013). 
When DAF-2 is activated by binding to an insulin-like peptide (e.g. DAF-28), it recruits and activates the 
phosphoinositide 3-kinase, AGE-1, which coverts PIP2 to PIP3. PIP3 leads to activation of the 
serine/threonine kinases PDK-1 and AKT-1/2, which cause the FOXO transcription factor DAF-16 to be 
phosphorylated. Phosphorylated DAF-16 is retained in the cytosol and prevented from entering the 
nucleus. Upon loss of daf-2, the phosphatase daf-18/PTEN which counteracts AGE-1 and AKT-1 activity, 
leads to an increase of dephosphorylated DAF-16 (Ogg and Ruvkun 1998). Consequently, DAF-16 is active 
and enters the nucleus to mediate the transcription of effector genes. Knock out of daf-2 leads to an 
increase of overall body fat in C. elegans, which is mediated by daf-16 (Ogg et al. 1997). How precisely 
loss of daf-2 mediates increased fat levels is, as yet, unknown. 
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Figure 4: TGFβ signaling pathway in fat metabolism: 
Binding of DAF-7 to the receptors DAF-1/DAF-4 blocks DAF-
3 activity and inhibits dauer entry. See text for details. 
 
TGFβ (Transforming Growth Factor β) signaling mediates many aspects of development, cell specification, 
function and survival (Zhu and Burgess 2001). In C. elegans there are five ligands that belong to the TGFβ 
family: dbl-1, unc-129, tig-2, tig-3, daf-7 (Gumienny and Savage-Dunn 2013). The latter was shown to be 
involved in fat metabolism. DAF-7 acts by binding to the receptors DAF-1 or DAF-4 (Estevez et al. 1993; 
Georgi, Albert, and Riddle 1990) which leads to inhibition of DAF-3, a receptor-associated coSMAD, and 
therefore blocks dauer-entry and promoted reproductive growth (Patterson et al. 1997). DAF-3 mediated 
dauer formation depends on the nuclear receptor (former: nuclear hormone receptor) DAF-12 (Antebi et 
al. 2000). Unlike the receptors DAF-1 and DAF-4 which are expressed in many neurons, DAF-7 only 
localizes in one specific pair of ASI sensory neurons (Ren et al. 1996) in the head. Mutation of daf-7 (or 
daf-1/daf-4) leads to a 20-25% reduced feeding rate, accompanied by a 2.5-fold increase in total body fat 
(Kimura et al. 1997) and depend on daf-3 (Greer et al. 2008). However, loss of daf-12 does not rescue the 
increase of fat or feeding defect seen in daf-7 mutants. Hence, fat and feeding related phenotypes are 
regulated independently from dauer entry (Greer et al. 2008). In addition, daf-7 mutants exhibit increased 
de-novo fat synthesis by the fatty acid synthesis fasn-1 (Antebi et al. 2000). Animals often leave their 
bacteria batch to find high quality food, which supports optimal growth and reproduction. This foraging 
behavior is, among others, also depending on daf-7 (Milward et al. 2011). It is likely that DAF-7 under 
normal conditions controls normal fat accumulation whereas during unfavorable condition, which would 
lead to dauer formation, daf-7 is inhibited and fat stores are increased to improve changes of survival.  
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Figure 5: Serotonin signaling in fat metabolism 
See text for details. (Palamiuc et al. 2017) and 
(Srinivasan et al. 2008) were used as basis for the 




Serotonin (5-hydroxytryptamine (5-HT)) is a potent neurotransmitter which, in C. elegans, is synthesized 
by the conserved tryptophan hydroxylase TPH-1. Many nutrition-related phenotypes such as feeding, egg 
laying, fat storage, reproductive life cycle and foraging are affected by loss of tph-1 (Sze et al. 2000). In 
tph-1 deletion animals, DAF-7::GFP fusion protein is strongly upregulated in the ASI neuron (i. e. TGFβ 
signaling is upregulated) and their increased fat storage partially depends on daf-3. Thus, the excess fat 
seen upon loss of tph-1 can, to some extent, be explained by an increase of TGFβ signaling (Sze et al. 
2000). Similar to mutants of the TGFβ pathway, serotonin modulates feeding behavior independent of fat 
accumulation (Noble, Stieglitz, and Srinivasan 2013). Serotonin is produced in the ADF chemosensory 
neurons and bound by MOD-1, a serotonin-gated chlorine channel (Ranganathan, Cannon, and Horvitz 
2000). Activation of MOD-1 in the URX neurons ultimately induces lipid break down in the intestine, which 
leads to the accumulation of β-oxidation intermediates that modulate feeding behavior (Noble, Stieglitz, 
and Srinivasan 2013; Srinivasan et al. 2008). Thus, feeding is controlled by internal and external cues. After 
activation of MOD-1, FLP-7, a neuropeptide localized in ASI neurons (Palamiuc et al. 2017) is released 
depending on AMPK (AAK-29 signaling). When FLP-7 binds to NPR-22, a receptor expressed in the 
intestine, downstream signaling leads to transcriptional activation of the ligase ATGL-1 and increase of β-
oxidation genes which diminishes fat stores (Palamiuc et al. 2017).  In addition, MOD-1 activation also 
relays a signal to RIC neurons to release octopamine, the invertebrate analogue of adrenaline. Binding of 
octopamine by the G-protein coupled receptor, SER-6 in the AWB neurons a permissive cue to maintain 
5-HT signaling by regulating tph-1 expression (Noble, Stieglitz, and Srinivasan 2013).  
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1.1.5 Regulation of fat metabolism and alteration during different physiological conditions 
During the course of an animals` life the availability of food and the way food is processed can vary 
tremendously. Depending on nutritional status, feeding is initiated or abandoned (Juozaityte et al. 2017) 
and while in young animals, only few ectopic fat reserves are visible, they become more pronounced in  
aged animals (Palikaras et al. 2017). These phenotypes are neither a passive consequence of time or the 
absence or presence of an outside stimulus (e.g. food density), but are actively regulated and can be 
genetically manipulated. Transcriptional regulation of fat metabolism is extensively studied in mammals 
and most key transcription factors have homologs in C. elegans (Atherton et al. 2008; McKay, McKay, et 
al. 2003). The mammalian PPAR-γ (Peroxisome proliferator-activated receptor gamma) is a nuclear 
receptor expressed in adipose tissue (Fajas et al. 1997) where it stimulates lipid uptake and adipogenesis 
(Tontonoz, Hu, and Spiegelman 1994). The functional homolog in C. elegans, NHR-49 (Atherton et al. 
2008), controls fat consumption and fatty acid composition (Taubert et al. 2006; Van Gilst et al. 2005) in 
ad libitum fed animals and activates β-oxidation upon food deprivation (Van Gilst, Hadjivassiliou, and 
Yamamoto 2005). Furthermore, nhr-49 mutants exhibit a shortened life span, which is caused by their 
impaired expression of stearoyl CoA desaturase (Van Gilst et al. 2005). NHR-49 functions as transcriptional 
activator together with its co-activator MDT-15 (Taubert et al. 2008; Taubert et al. 2006) and represses 
transcription when paired with NHR-66 (Pathare et al. 2012). How exactly NHR-49 achieves target 
specificity and how its activity can be modulated depending on the cell’s needs remain elusive. However, 
a recent study could show that distinct point mutations in the ligand binding domain affect NHR-49 target 
specificity suggesting that distinct ligands may influence NHR-49 activity (Lee et al. 2016).  
Krüppel-like transcription factors have various roles in the regulation of an animal’s physiology. In recent 
years, they have emerged as regulators of mammalian fat metabolism (Brey et al. 2009; Wu and Wang 
2013). Similarly, in C. elegans, klf-1 (Krüppel-like factor) is essential for fat metabolism, cell death and 
phagocytosis. (Hashmi et al. 2008). Loss of either klf-1 or one of its orthologues klf-2 or klf-3 leads to an 
increase in overall body fat (Hashmi et al. 2008; Ling et al. 2017). KLF-2 and to some extent KLF-3, might 
influence lipid metabolism by regulating lpd-1 (alternative name: sbp-1) and lpd-2, homologs of SREBP 
and NGDN (Neuroguidin), respectively (Hashmi et al. 2008). SREBPs (sterol regulatory binding protein) 
belong to a family of transcription factors that bind the conserved sterol element ATCACCCCAC (Kim et al. 
1995) and regulate lipid metabolism in mammals (Eberle et al. 2004).  SBP-1 together with its co-activator 
MDT-15 are needed for fatty acid homeostasis (Yang et al. 2006). Loss of sbp-1 and mdt-15 can be rescued 
by dietary supplementation with oleic acid, suggesting that their major physiological task is the regulation 




Lack of food induces different behavioral and metabolic changes in animals. In C. elegans, depending on 
the developmental status, absence of nutrients can have life-changing consequences. L1 larvae hatch in 
an arrested state and only develop further in the presence of food (Baugh 2013). Later, when they reach 
L2 stage, the absence of food or high population density induces dauer formation, an alternative 
developmental stage associated with high fat stores, a thin needlelike body shape and high motility 
(Albert, Brown, and Riddle 1981; Gaglia and Kenyon 2009; Gems et al. 1998; Klass and Hirsh 1976; Ogg et 
al. 1997). Fat metabolism in dauer larvae is drastically altered and high fat content in the gut can be 
observed (Burnell et al. 2005). To avoid premature depletion of these fat deposits, AMPK monitors and 
inhibits the activity of the lipase ATGL-1 via phosphorylation (Narbonne and Roy 2009). This 
phosphorylation generates 14-3-3 binding sites which are recognized by PAR-5, a 14-3-3 protein 
orthologue, that sequesters ATGL-1 away from the lipid droplets, leading to reduced lipid hydrolysis and 
degradation of ATGL-1 (Xie and Roy 2015). Reduced AMPK signaling leads to an increase of ATGL-1-
dependent lipolysis and consequently to reduced lifespan of dauer animals (Narbonne and Roy 2009). In 
contrast to this, during food deprivation in adulthood animals, increasing cAMP levels stimulate protein 
kinase A (PKA) to induce lipolysis via the lipid droplet protein LID-1 and ATGL-1 (Lee et al. 2014). AMPK 
signaling also induces lipid degradation via hormone-sensitive lipase HOSL-1 during cold-stress, which 
leads to glycerol accumulation and protection from cold-induced damage (Liu et al. 2017). Hence, the fine 
balance between lipid hydrolysis and retention is crucial for survival during certain stresses and dauer 
stage. After exit of dauer, animals enter L4 larval stage and develop into adults normally.  When adult 
animals experience food depletion, they show increased motility while at the same time reducing their 
rate of pharyngeal pumping and in case of gravid adults, retaining eggs and embryos (Avery and Horvitz 
1990; Hills, Brockie, and Maricq 2004; Sawin, Ranganathan, and Horvitz 2000). The latter is also known as 
adult reproductive diapause and protects germline stem cells at the expense of the rest of the germline 
cells, leading to an extension of the reproductive lifespan (Angelo and Van Gilst 2009). Genome-wide 
proteomics of adults that undergo acute starvation show, somewhat expected, that major fat metabolic 
enzymes are differentially expressed (Larance et al. 2015). Additionally, chromatin-associated proteins 
are misregulated, suggesting a more permanent influence on gene expression (Larance et al. 2015). During 
starvation, depletion of fat-deposits, and hence survival, depends on various fasting-induced lipases (FILs) 
(Jo et al. 2009; O'Rourke and Ruvkun 2013). The ER is an organelle closely associated with fat metabolism. 
IRE-1, an ER-resident transmembrane serine/threonine protein kinase, known to be induced by an 
accumulation of unfolded proteins in the ER, and HSP-4, an ER chaperone, regulate fat degradation by 
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influencing the expression of the fasting induced lipases FIL-1 and FIL-2 (Jo et al. 2009), which are related 
to the mammalian adipose triglyceride lipases (ATGL) (Zimmermann et al. 2004). When starvation is 
induced in ire-1RNAi or hsp-4RNAi animals, fat stores are maintained and life span during long-term 
starvation is compromised (Jo et al. 2009). Lipl-1-5 are intestinal lipases that are induced upon starvation 
and lipl-1 and lipl-3 are responsible for lipolysis during starvation. During ad libitum feeding, the 
transcription factor MXL-3 represses lipl-1, -2, -3, and lipl-5 (but not lipl-4), which are de-repressed as mxl-
3 levels decline during starvation (O'Rourke and Ruvkun 2013).  In contrast to MXL-3, the transcription 
factor HLH-30 is a positive regulator of lipases during starvation and transcriptionally activates lipl-2, -3 
and -5. (O'Rourke and Ruvkun 2013). In the same study, it was shown that lipid accumulation also depends 
on the two autophagy genes lgg-1 and lgg-2. Autophagy that serves in lipid hydrolysis is also termed 
lipophagy and plays an important role in lipid homeostasis. Loss of important autophagy genes such as 
bec-1, related to the mammalian autophagy gene Atg-6, leads to a decrease in overall lipid levels (Lapierre 
et al. 2013).  
1.1.5.2 Variation of food source 
Fat content of an animal is highly influenced by the dietary intake. In the lab the main source of nutrients 
for C. elegans is the E. coli strain OP50.  However, it was shown that OP50 represents a rather low quality 
food judging by the time the animals spend quiescent on the bacteria lawn (You et al. 2008) and might 
even be slightly pathogenic (So et al. 2011). In their native environment the animals are associated with a 
species-rich microbiome dominated by variety of Proteobacteria (Dirksen et al. 2016). Furthermore, 
during RNAi knock down experiments, the E. coli strain HT115 is used for feeding. HT115 and HB101 have 
a higher carbohydrate content compared to OP50 and lead to a decrease of internal fat stores quantified 
via fixed Nile red staining (Brooks, Liang, and Watts 2009). This difference may be dependent on the 
uptake of peptides, because a mutation in pept-1 (formerly known as opt-2 or pep-2), an intestinal peptide 
transporter, abolishes the diet-dependent fat-change (Brooks, Liang, and Watts 2009). Lifespan, a readout 
for overall health of the animals, is only slightly increased. Further studies showed that feeding with E. 
coli strain HB101 leads to an increase of lifespan independent of daf-2 and a 1.6- fold increase in the 
animals’ body size, which is daf-2 dependent (So, Miyahara, and Ohshima 2011; So et al. 2011).  
1.1.5.3 Aging 
In mammals, during the process of aging, lipid homeostasis is lost and consequently excess lipids are 
deposited in and around non-adipose tissues such as neurons and muscles. Consequences are overall 
decline of health, locomotion defects and eventually organ dysfunction and death, which can also be 
18 
  
observed in C. elegans. Deposition of ectopic fat is strongly delayed in long-lived mutants such as eat-
2(ad465), daf-2(e1370), and glp-1(e2141) (Palikaras et al. 2017).  
1.2 Regnase-1 and Regnase-1-related proteins  
As described in chapter 2.1 “Ribonuclease-mediated control of body fat”, we uncovered a hitherto 
uncharacterized RNase involved in C. elegans fat metabolism. We identified rege-1 in a screen, using cold 
sensitivity as read out to uncover novel fat key factors in fat regulation. REGE-1 is important for wild type 
levels of fat and rege-1 mutants exhibit a strong upregulation of fat metabolic and innate immunity genes, 
depending on the transcription factor ETS-4 (Habacher et al. 2016). REGE-1 is a close homolog of the 
mammalian Regnase-1, a well-studied regulator of innate immunity and potentially adipogenesis 
(reviewed in (Jura, Skalniak, and Koj 2012; Mao et al. 2017; Uehata and Akira 2013)). Previously to this 
study, high throughput research examined GFP under the control of the putative C30F12.1 promoter and 
reported expression in the intestine, somatic gonad and head neurons (McKay, Johnsen, et al. 2003). 
Additionally, one genome-wide RNAi study found that knock down of C30F12.1 causes a pale phenotype, 
a possible sign for reduced body fat (Simmer et al. 2003), another reported decreased Nile red live staining 
(Ashrafi et al. 2003), which reflects a decrease of lysosome related organelles (O'Rourke et al. 2009). 
Hence, the exact function and involvement in fat metabolism of C30F12.1/rege-1 was elusive.  
Following chapter was published in the journal “BioEssays”: DOI: 10.1002/bies.201700051 
THE (RNA) CUTTING EDGE OF ZC3H12A/MCPIP1/REGNASE-1–RELATED ENDONUCLEASES 
Cornelia Habacher1,2 and Rafal Ciosk1,* 
ABSTRACT 
The mammalian Zc3h12a/MCPIP1/Regnase-1, an extensively studied regulator of inflammatory response, 
is the founding member of a ribonuclease family, which includes proteins related by the presence of the 
so-called Zc3h12a-like NYN domain. Recently, several related proteins have been described in 
Caenorhabditis elegans, allowing comparative evaluation of molecular functions and biological roles of 
these ribonucleases. We discuss the structural features of these proteins, which endow some members 
with ribonuclease (RNase) activity while others with auxiliary or RNA-independent functions. We also 
consider their RNA specificity and highlight a common role for these proteins in cellular defense, which is 
remarkable considering the evolutionary distance and fundamental differences in cellular defense 




With the exception of certain developmental stages and specific cell types, protein abundance is typically 
linked to the abundance of mRNA. This, in turn, is determined by the transcriptional output, mRNA 
modifications, and the association with regulatory RNA-binding proteins (RBPs) and non-coding RNAs. An 
important class of RBPs affecting RNA stability are ribonucleases (RNases), which catalyze RNA cleavage. 
These enzymes degrade RNA either from the 3' or 5' ends (exonucleases) or via internal cleavage 
(endonucleases). Depending on their mode of action and architecture, RNases are assigned to different 
families. Here, we focus on RNases belonging to the PIN- (PilT N-terminal) domain superfamily that are 
related to the endonuclease Zc3h12a/MCPIP1/Regnase-1, for brevity Regnase-1. 
 The PINendonuclease superfamily (CL0280), according to the Pfam protein database 
(www.pfam.xfam.org), includes eighteen families. Proteins related to Regnase-1 fall into two of these 
families, RNase_Zc3h12a (PF11977) and RNase_Zc3h12a_2 (PF14626), both of which are characterized by 
the presence of Zc3h12a-like NYN domains. Somewhat confusingly, proteins containing a related NYN 
domain (Anantharaman and Aravind 2006), originally named after the mammalian Nedd4-binding protein 
1 (N4BP1) and bacterial YacP nucleases, belong to a distinct family. The Zc3h12a-like NYN domain is 
present in all three domains of life; in eukaryotes, the domain underwent functional diversification and 
fusion to additional functional domains. Regnase-1 is perhaps the most-studied protein carrying the 
Zc3h12a-like NYN domain; it is a critical regulator of inflammatory response, with additional roles in 
defense against viruses and various stresses, cellular differentiation and apoptosis (reviewed in (Jura, 
Skalniak, and Koj 2012; Mao et al. 2017; Uehata and Akira 2013)). Regnase-1 was first implicated in innate 
immunity when it was shown to be induced by the Monocyte chemoattractant protein-1 (MCP1), a 
chemokine that mediates inflammatory response – hence its other name, MCPIP1 (MCP1-induced protein 
1) (Bidzhekov, Zernecke, and Weber 2006; Zhou et al. 2013). MCPIP1 was initially thought to be a 
transcription factor, but was later discovered to localize in the cytoplasm and regulate mRNA abundance 
by nucleolytic cleavage, which is why it was eventually re-named as Regnase-1 (regulatory RNase-1) 
(Iwasaki et al. 2011). Curiously, in addition to its RNA-cleaving function, the Zc3h12a-like NYN domain has 
been suggested to function as a deubiquitinase (Liang et al. 2010). However, how/whether these RNA and 
protein-regulatory functions relate to each other is not yet clear.  
 Recently, several reports have put the spotlight on C. elegans proteins related to Regnase-1. The 
closest homolog, REGE-1 (REGnasE-1), carries the same functional domains as Regnase-1, and, like its 
mammalian namesake, functions as a cytoplasmic endonuclease. By targeting mRNA encoding a 
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transcription factor, REGE-1 regulates the expression of genes involved in  fat  metabolism and and innate 
immunity genes (Habacher et al. 2016). A more distantly related C. elegans protein, RDE-8, together with 
several paralogs, has been implicated in RNA interference (RNAi) pathways (Tsai et al. 2015). With the 
recent description of nematode proteins REGE-1 and RDE- 8, the molecular functions and biological roles 
of proteins that belong to the Zc3h12a-like NYN domain family can be examined now from the 
evolutionary perspective. Here, we discuss potential molecular functions of these family members and 
highlight their, apparently ancient, roles in the regulation of cellular defense and homeostasis.  
MAIN TEXT 
The RNase activity and domain architecture of Regnase-1–related proteins 
Proteins related to Regnase-1 share crucial structural and functional features. Towards the C-terminus of 
the Zc3h12a-like NYN domain, they typically contain four aspartic acids forming the catalytic center of the 
active site. These aspartic acids chelate a magnesium ion to activate a water molecule for nucleophilic 
attack at the phosphodiester bond of the RNA backbone (Anantharaman and Aravind 2006). Both, 
physicochemical properties and the spatial orientation of these residues relative to each other are crucial 
for the catalytic activity. Substitution of only one of the four charged aspartic acids (D141 of Zc3h12a) by 
a polar, uncharged asparagine abolishes the RNase activity (Matsushita et al. 2009). A representative 
structure of the Zc3h12a-like NYN domain from Regnase-1 (Protein Data Bank entry 3V34)is shown in 
Figure 1. In some of the Regnase-1–related proteins, the conserved aspartic acids are substituted by other 
amino acids, suggesting that these proteins no longer cleave RNA. The phylogenetic relationships of 
selected Regnase-1–related proteins, together with their domain architecture, are shown in Figure 2.  
In vitro, the RNase domain of Regnase-1 alone binds to RNA inefficiently and, consequently, is incapable 
of RNA degradation (Xu, Peng, et al. 2012; Yokogawa et al. 2016)  Hence, additional domains and/or co-
factors are necessary for RNA binding and degradation. Specificity towards RNA can be achieved by RNA-
binding domains (RBDs) or by interactions with RBPs. Most functional Zc3h12a-like NYN-domain proteins 
contain an RBD, such as a zinc finger (ZF) or a K-homology (KH) domain (Fig. 2). Regnase-1 harbors a CCCH-
type ZF: In vitro, the CCCH ZF increases the binding strength of Regnase-1 to RNA, thereby increasing the 
efficiency of RNA cleavage (Yokogawa et al. 2016). An additional conserved domain, the N-terminal 
domain (NTD), increases the affinity to RNA and is necessary for efficient RNA cleavage in vitro (Yokogawa 
et al. 2016). Moreover, the Zc3h12a-like NYN domain appears to form a head-to-tail dimer, which, at least 
in vitro, is needed for the ribonuclease activity of Regnase-1 (Yokogawa et al. 2016). The conserved C-
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terminal domain consists of a three-helical bundle and has been suggested to be expendable for 
degradation of most Regnase-1 mRNA targets (Yokogawa et al. 2016); however it may play a role during 
degradation of pre-mi RNA (Suzuki et al. 2011). Hence, both intra- and intermolecular interactions appear 
to govern Regnase-1 activity. 
Regnase-1 activity is also influenced by other proteins. In T cells, Regnase-1 co-operates with another 
CCCH ZF RBP, Roquin (Jeltsch et al. 2014). This co-operation requires the nuclease activity of Regnase-1 as 
well as the RNA-binding ability of Roquin. A hybrid protein, harboring the RBP domain of Roquin fused to 
full-length Regnase-1, rescues mRNA regulation in cells devoid of endogenous Roquin and Regnase-1 
(Jeltsch et al. 2014). These observations suggest that Roquin may recruit Regnase-1 to specific mRNA 
targets. However, a more recent study, using other cell types, suggests that, although Roquin and 
Regnase-1 control shared mRNAs, they do so in different sub-cellular compartments and by different 
mechanisms (Mino et al. 2015). According to this latter model, Regnase-1, with the help of UPF1 (a 
helicase functioning in nonsense-mediated RNA decay), degrades mRNAs during translation. Thus, the co-
operation between Regnase-1 and Roquin is either cell-specific or incompletely understood.  
Interactions with co-factors have been also demonstrated for family members lacking obvious RBDs. C. 
elegans RDE-8, which contains a functional Zc3h12a-like NYN domain but no obvious RBD, interacts with 
RDE-1, an Argonaute protein and a key player in RNA interference (RNAi) pathways (Tsai et al. 2015). RDE-
1 is loaded with small interfereing RNAs (siRNAs), which guide RDE-1 and associated proteins to mRNA 
targets. Thus, the association with RDE-1 has been suggested to provide RNA specificity to RDE-8–
mediated RNA degradation. Interestingly, RDE-8 also interacts with its paralogs NYN-1, NYN-2 and ERI-9 
(Tsai et al. 2015). Although these paralogs carry subsitutions in the conserved aspartic acids of the 
Zc3h12a-like NYN domain, and so are thought be RNase-dead (Fig. 2), they are required for certain siRNA 
pathways (Tsai et al. 2015). In the absence of NYN-1 and NYN-2, immunoprecipitation of a catalytic-dead 
RDE-8 (D76N; allowing to capture the protein on RNA, which is otherwise rapidly degraded) showed 
reduced association between RDE-8 and its mRNA target (Tsai et al. 2015). Thus, although the precise role 
of the interaction between RDE-8 and its paralogs remains to be determined, these proteins have been 






Dynamic regulation of the RNase activity 
Regulation of mRNA is a fast, and potentially reversible way of tuning gene expression to cellular demands, 
imposed by extracellular cues and intracellular fluctuations. As Regnase-1 functions in dosage-sensitive 
pathways, perhaps it comes as no surprise that its expression is tightly controlled: Regnase-1 is targeted 
to proteosomal degradation by IKB kinases or cleaved by the paracaspase MALT-1 (Iwasaki et al. 2011; 
Jeltsch et al. 2014; Uehata et al. 2013). It is also subjected to a sophisticated feedback regulation. For 
example, Regnase-1 cleaves its own transcript (Mizgalska et al. 2009; Uehata et al. 2013; Wawro, Kochan, 
and Kasza 2016) and its direct targets, IL-17 and IL-1β, induce Regnase-1 expression via different 
mechanisms (Garg et al. 2015; Mizgalska et al. 2009; Ruiz-Romeu et al. 2016; Somma et al. 2015). 
Presumably, these feedbacks ensure a correct dosage of the RNase activity, leading to a desired 
remodeling of the transcriptome. Interestingly, also C. elegans  REGE-1 appears to be a subject of feedback 
regulation, as it degrades mRNA of its own transcriptional activator, ETS-4 (Habacher et al. 2016). In this, 
considerably simpler model, quantitative measurements and mathematical modeling of the feedback 
regulation may be more straightforward, potentially leading to a deeper understanding of the RNase 
function and regulation. 
Features of RNA targets 
Regnase-1 and its homolog REGE-1 cleave their mRNA targets within specific 3'UTR regions. Many 3'UTRs 
contain AU-rich elements (AREs) that, by recruiting RBPs, influence mRNA stability. Specifically CCCH ZF-
containing proteins are known regulators of ARE-containing transcripts (Hudson et al. 2004; Lai, 
Kennington, and Blackshear 2002). In contrast, Regnase-1–dependent degradation of IL-2 and IL-6 mRNAs 
appears to be independent of the ARE sequences; instead, it requires RNA stem loops (Li et al. 2012; 
Matsushita et al. 2009). A large-scale study aiming at the identification of putative  Regnase-1 targets 
revealed a three-nucleotide loop consensus motif (preferentially UAU or UGU) which was necessary for 
interaction with Regnase-1(Mino et al. 2015); whether these associated mRNAs are genuine targets 
remains to be determined. The stem loop within the IL-2 3`UTR consists of about 20 nucleotides and 
mutations that abolish formation of the loop render mRNA insensitive to Regnase-1-mediated cleavage. 
However, because additional mutations restoring the stem did not restore the cleavage, a combination of 
sequence and structure has been proposed to determine mRNA cleavage by Regnase-1 (Li et al. 2012). 
Similarly, while cleaving its own transcript, Regnase-1 appears to rely on both stem loops and the 
surrounding sequence (Wawro, Kochan, and Kasza 2016). In C. elegans, REGE-1 cleaves the 3'UTR of ets-
4 mRNA at a specific position within a roughly 100 nucleotide-long region. This region harbors many 
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potential stem loops (our unpublished observation). However, whether the requirement for stem loops is 
a conserved feature of RNA degradation by REGE-1 remains to be tested.  
Besides targeting mRNA, Regnase-1 is reported to play a role in micro RNA (miRNA) processing. Initially, 
miRNAs are produced as primary miRNAs (pri-miRNAs) that can be several hundred nucleotides-long. 
Subsequently, pri-miRNAs undergo extensive processing to yield mature miRNAs, which are loaded onto 
Argonaute proteins, guiding them to specific mRNAs containing complementary sequences (Kim, Han, and 
Siomi 2009; Kobayashi and Tomari 2016). The biogenesis and maturation of miRNAs are tightly controlled. 
Regnase-1 was shown to cleave the terminal loop of pri-miRNAs, thereby inhibiting their maturation 
(Suzuki et al. 2011). Hence, in case of certain miRNAs, Regnase-1 appears to counteract Dicer and its 
mRNA-silencing function. This anti-dicer function was also observed in inflammation-induced 
angiogenesis, where Regnase-1 degrades the anti-angiogenic miR20b and miR34a (Roy et al. 2013). In 
addition, Regnase-1 was shown to degrade viral miRNAs,  which, in turn, were shown to degrade Regnase-
1 mRNA, potentially facilitating infection (Happel, Ramalingam, and Ziegelbauer 2016). However, the 
cleavage of pri-miRNA by Regnase-1 might depend on the specific context, as the same miRNAs that were 
reportedly degraded by Regnase-1 in HepG2 cells (human liver cancer cells) (Suzuki et al. 2011), were not 
affected by the depletion of Regnase-1 in mouse embryonic fibroblasts (Mino et al. 2015).  
Control of protein ubiquitination 
The amount, the type, and the position of ubiquitin linked to a target proteinhave diverse effects on 
protein stability, localization and activity. In general, chains of ubiquitin which are covalently linked via 
Lys48 (K48) to a target protein, mark it for degradation via the proteasome. In contrast, chains connected 
via Lys63 (K63) alter target protein activity. In vitro, Regnase-1 -is able to remove both types of chains, 
and a specific residue in the Zc3h12a-like NYN domain, C157 in Zc3h12a, is essential for deubiquitination 
but expendable for the RNase activity (Liang et al. 2010). In vivo, Regnase-1 has been reported to stabilize 
HIF1α (Roy et al. 2013) and modify the activity of TRAFs (Liang et al. 2010), by promoting de-
ubiquitination. Thus, apparently through the same domain, Regnase-1 is capable of regulating the stability 
of either protein or RNA. Somewhat similar, a related protein, Nedd-4-binding partner 1 (N4BP1), 
predicted to have an RNase activity (Fig. 2), controls ubiquitin-mediated degradation by inhibiting a 
specific E3 ligase (Oberst et al. 2007). Interestingly, Roquin, functionally related to Regnase-1 as discussed 
above, contains a RING-type E3 ligase domain and promotes protein ubiquitination, potentially 
counteracting the de-ubiquitinating function of Regnase-1 (Ramiscal et al. 2015; Zhang, Fan, et al. 2015). 
Intriguingly, also the C. elegans homolog of Roquin, RLE-1, is reported to function as an E3 ligase (Li et al. 
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2007). However, whether RLE-1 contributes to REGE-1–mediated mRNA degradation, and whether REGE-
1 controls protein stability, remains to be examined.  
Biological roles of Regnase-1–related proteins 
Regnase-1 negatively regulates pro-inflammatory transcripts, including IL-6 and IL-12p40, in resting T-cells 
(Matsushita et al. 2009). Upon T-cell activation, Regnase-1 is phosphorylated by IKB kinases (IKKs) and 
degraded in an ubiquitin-dependent manner (Iwasaki et al. 2011). In addition, the paracaspase MALT-1 
directly cleaves Regnase-1, thereby stabilizing Regnase-1 targets (Jeltsch et al. 2014; Uehata et al. 2013). 
Mice lacking functional Regnase-1 develop auto-antibodies and die, postnatally, of systemic inflammation 
(Matsushita et al. 2009; Miao et al. 2013; Zhou et al. 2013). Regnase-1 knockout specifically in T-cells lead 
to a similar phenotype, suggesting that the phenotype is caused by the loss of Regnase-1 in these immune 
system cells (Iwasaki et al. 2011). Thus, Regnase-1 is crucial to suppress the autoimmune response under 
non-immunogenic conditions. Additionally, Regnase-1 exhibits broad-spectrum antiviral effects (Lin et al. 
2013). Among others, it degrades RNAs of HIV (Human Immunodeficiency Virus) and HCV (Hepatitis C 
Virus), and restricts the replication of some DNA viruses such as adenovirus by an unknown mechanism 
(Lin et al. 2014; Liu et al. 2013). Additionally to Regnase-1, the mammalian genome encodes three more, 
less-studied, homologs Zc3h12b-d/Regnase-2–4. Zc3h12d is upregulated upon endotoxin exposure, and 
its knockdown leads to a strong increase in the levels of IL-1β, IL-6 and TNF-α, as well as other transcripts 
encoding additional inflammatory factors (Zhang, Wang, et al. 2015). Degradation of these mRNAs 
depends on the intact RNase domain of Zc3h12d (Wawro et al. 2017). Although Zc3h12a and Zc3h12d 
appear to target common transcripts and seem to interact by co- immunoprecipitation, they act 
independently in degrading IL-6 mRNA (Huang et al. 2015). Another family member, Zc3h12c, was shown 
to be induced by TNFα and overexpression of it represses pro-inflammatory signals, such as IL-8 and MCP-
1, in HUVEC cells (Liu et al. 2013). Furthermore, overexpression and mutations in Zc3h12c have been 
linked to psoriasis (Munir et al. 2015; Tsoi et al. 2012). A more direct evidence for the involvement of the 
Zc3h12a-family in chronic skin inflammation comes from studies on Zc3h12a, which is both stimulated by 
IL-17 and degrades IL-17 mRNA during chronical skin inflammation (Monin et al. 2017; Ruiz-Romeu et al. 
2016). 
 Among nematode proteins, the closest counterpart of Regnase-1, REGE-1, targets mRNA encoding 
a transcription factor, ETS-4, which in turn controls expression of target genes. Many of these genes have 
been implicated in nematode innate immunity (Habacher et al. 2016). Thus, although Regnase-1 directly 
controls mRNAs encoding immunity factors and REGE-1 appears to do so indirectly, both RNases play roles 
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in cellular defense. Also RDE-8, together with its paralogs described above, has a role in cellular defense, 
by functioning in RNAi pathways protecting against transposons; it may also defend against nematode 
viruses (Tsai et al. 2015). Thus, Regnase-1–related proteins play apparently ancient roles in cellular 
defense, which is remarkable considering major differences in the defense mechanisms between 
nematodes and mammals (Irazoqui, Urbach, and Ausubel 2010; Pradel and Ewbank 2004). It is tempting 
to speculate that this functional conservation might be due to a special relationship between cellular 
defense-oriented signaling pathways and their effector RNases, whose targets have changed over the 
course of evolution.  
CONCLUSIONS 
Recent publications on Regnase-1 and related proteins brought these important RNA regulators into 
focus. However, most family members, including proteins being studied in major animal models such as 
zebrafish and fruit fly, remain poorly or not characterized. Based on the critical functions of Regnase-1 in 
mammalian immunity and the essential functions of the nematode protein REGE-1 in fat metablism, other 
Regnase-related proteins may be expected to play important functions in defense and homeostasis. A 
defining feature of Regnase-1–related proteins is the Zc3h12a-like NYN RNase domain. However some 
family members carry substitutions in the active site, suggesting that they do not function as RNases. 
Although some of these proteins may have adopted entirely different functions, others appear to fulfill 
auxiliary roles in RNA regulation. For example, nematode NYN-1 and NYN-2 are dispensable for the RNase 
activity of RDE-8 in vitro but, in vivo, they are required for RDE-8–mediated RNA regulation, possibly by 
facilitating the formation of an RNA-silencing complex. Thus, dissecting precise functions of the pseudo-
RNase proteins related to Regnase-1 is an important goal for the future. 
A key feature of Regnase-1 and REGE-1 is their high RNA specificity, which, however, remains poorly 
understood. Most observations suggests that the RNase domain is insufficient for RNA specificity. Some 
of the proteins carry RBDs, such as the CCCH ZF of Regnase-1 or the KH domain of N4BP1, which were 
either shown or are expected to improve affinity to RNA as well as specificity. Others, which do not carry 
any recognizable RBDs, may interact with RBPs, similar to RDE-8, which is recruited to mRNA targets by 
RDE-1. However, RNA recognition of even stand-alone RNases, such as Regnase-1, may be more 
complicated than previously thought: To efficiently cleave RNA in vitro, Regnase-1 forms a homodimer, in 
which one of the proteins is cleaving RNA whereas the other might serve structural purposes (Yokogawa 
et al. 2016). Also understanding the functional relationship between Regnase-1 and Roquin needs further 
work, and studies on the closest homologs, like REGE-1, are expected to bring new insights. Finally, also 
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RNA features underlying the RNase's specificity remain to be further investigated. Regnase-1–dependent 
cleavage requires RNA stem loops: Whether these stem loops are needed for Regnase-1 binding and/or 
the cleavage remains unclear. Also, whether RNA structure is important for RNA regulation by other family 
members remains to be seen. Thus, understanding precisely how Regnase-1–related proteins achieve RNA 
specificity, which is expected to differ between family members, remains a top priority, necessary to fully 




Figure 1: Representative structure of a Zc3h12a-like NYN domain.  
The crystal structure of the RNase domain of human Regnase-1 is depicted as a cartoon model in two 
orientations, with α-helices in yellow and β- strands in blue (Protein Data Bank entry 3V34, (Xu, Peng, et 
al. 2012)). View from the “top” onto the active center (left) turned by 90° along the x- and y-axis on the 
right. Highlighted in red are the four aspartic acids (D141, D225, D226, D244), which chelate a magnesium 
ion (green sphere) in the active center.  N- and C-termini are labelled and disordered loops which were 









Figure 2: Proteins related to Regnase-1 from selected model organisms.  
Left: Phylogenetic relationship of proteins related to Regnase-1 from H. sapiens, C. elegans, D. 
melanogaster and D. rerio. The alignment was constructed online with the multiple sequence alignment 
tool ClustalOmega (Goujon et al. 2010; McWilliam et al. 2013; Sievers et al. 2011). Default settings without 
tree branch corrections were used. Most of the proteins belong to the RNase_Zc3h12a family, with the 
exception of proteins on the light grey background, which belong to the RNase_Zc3h12a_2 family.  Right: 
Domain architectures corresponding to the proteins on the left. “RNase” indicates the Zc3h12a-like NYN 
domain. The four aspartic acids (corresponding to D141, D225/225, D244 of the human Regnase-1, from 
left to right) of the active center are highlighted. The domains in green contain all four aspartic acids and 
thus likely display an RNase activity. The domains in red contain substitutions of the conserved residues 
and probably do not function as RNases. Additional domains are indicated, according to the annotation in 
the Pfam protein database (http://pfam.xfam.org/). The domains are positioned relative to the RNase 
domain as in the actual proteins (to the left is the N- and to the right the C-terminus of the protein). The 
size of the boxes is not proportional to the length of the actual domains. “UBA” indicates a predicted 
ubiquitin-binding domain; “CCCH” a CCCH-type zinc finger domain; “CCR” a C-terminal conserved region; 






Figure 3: Biological roles of Regnase-1–related proteins connected to cellular defense.  
A comparison between mammalian and C. elegans proteins, highlighting roles related to cellular defense 
mechanisms: Modulation of inflammation, direct degradation of pathogenic RNA, and function in RNAi 
pathways, which can also function in cellular defense against either exogenous or endogenous (such as 
transposons) pathogenic agents.  
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SUMMARY 
Obesity is a global health issue, arousing interest in molecular mechanisms controlling fat. Transcriptional 
regulation of fat has received much attention and key transcription factors involved in lipid metabolism, 
such as SBP-1/SREBP, LPD-2/C/EBP and MDT-15, are conserved from nematodes to mammals. However, 
there is a growing awareness that lipid metabolism can be also controlled via posttranscriptional 
mechanisms. Here, we show that a previously uncharacterized Caenorhabditis elegans RNase, REGE-1, 
related to MCPIP1/Zc3h12a/Regnase-1, a key regulator of mammalian innate immunity, promotes 
accumulation of body fat. Using exon-intron split analysis (EISA), we find that REGE-1 promotes fat by 
degrading the mRNA encoding ETS-4, a fat loss-promoting transcription factor. Because ETS-4, in turn, 
induces rege-1 transcription, REGE-1 and ETS-4 appear to form an auto-regulatory module. We propose 
that this type of fat regulation may be of key importance when, faced with an environmental change, an 




Remodeling energy metabolism is critical for development, tissue homeostasis, and the etiology of 
numerous diseases including obesity and cancer (Folmes et al., 2012; Longo and Mattson, 2014; Ward and 
Thompson, 2012). Such remodeling can be induced by adverse environmental stimuli leading to a state of 
suspended animation or torpor. For example, hibernating animals use stored lipids, rather than 
carbohydrates, to fuel survival (Dark, 2005). In the wild, the C. elegans species populates temperate 
climates (Barrière and Félix, 2005), indicating that these animals are capable of surviving spells of cold. 
Indeed, when adapted to a decreasing temperature, C. elegans survives the exposure to near freezing 
temperatures (Murray et al., 2007; Ohta et al., 2014).  
In this study, we observed that also C. elegans utilize fat while in cold. Using cold sensitivity as the readout, 
we identified a putative RNase, REGE-1, related to the mammalian MCPIP1/Zc3h12a/Regnase-1, as a 
factor critical for C. elegans body fat accumulation. The examples of posttranscriptional regulation of fat 
remain few and are limited to specific miRNAs, whose functionally relevant mRNA targets remain, in most 
cases, unclear (Arner and Kulyté, 2015; Rottiers and Näär, 2012). In animals, miRNAs repress their mRNA 
targets through translational repression and/or exonucleolytic degradation (Wilczynska and Bushell, 
2015). By contrast, MCPIP1 is a PIN-domain endonuclease (Iwasaki et al., 2011; Matsushita et al., 2009; 
Xu et al., 2012), suggesting a possible requirement for the endonucleolytic mRNA degradation in C. 
elegans body fat regulation. Indeed, we demonstrate that REGE-1 controls body fat by targeting the 3’UTR 
of an mRNA encoding a fat loss-promoting transcription factor, ETS-4. Interestingly, while REGE-1 inhibits 
ETS-4, ETS-4 promotes the expression of REGE-1. Such an auto-regulatory module is particularly well 
suited for a dynamic control of gene expression. It may be of key importance when, faced in the wild with 
an environmental change, an animal must rapidly remodel its fat metabolism to maximize its chances for 
survival. 
RESULTS 
Cold-sensitivity screen reveals REGE-1 as a factor promoting body fat 
Extending the initial observations by others that C. elegans, when adapted to a decreasing temperature, 
can survive the exposure to near-freezing temperature (Murray et al., 2007; Ohta et al., 2014), we found 
that the animals can do so for many days, without a major impact on fecundity or lifespan (Fig. S1A-C). To 
what degree the C. elegans response to cold is analogous to that of hibernating animals is not clear. 
Nevertheless, consistent with fueling cellular processes by fat in hibernators, we observed a gradual 
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decline in the fat levels in “hibernating” C. elegans (Fig. S1D). This observation prompted us to use cold 
sensitivity as a readout to uncover new regulators of fat stores. We performed a genome-wide RNAi 
screen, searching for genes essential at 4 °C but non-essential at 20 °C (Fig. 1A). This approach uncovered 
factors implicated in diverse cellular processes (Figs. 1B and S1E). Importantly, the depletion of several 
factors caused a “pale” appearance of animals already at 20 ºC, indicating reduced stores of body fat. 
Indeed, some of these factors have established roles in fat metabolism (Fig. 1B). For example, the 
mediator complex component MDT-15 regulates expression of many fatty acid metabolism genes 
(Taubert et al., 2006), and FAT-6/7 are fatty acid desaturases previously implicated in cold survival (Murray 
et al., 2007; Watts and Browse, 2000). Additionally, knockdown of the hitherto uncharacterized gene 
C30F12.1 resulted in pale animals. C30F12.1 protein is a member of the CCCH-type zinc finger family (Liang 
et al., 2008) and is related to the mammalian MCPIP1/Zc3h12a/Regnase-1, a PIN-domain endonuclease 
(Xu et al., 2012), which directly degrades specific mRNAs such as those encoding proinflammatory 
cytokines (Iwasaki et al., 2011; Matsushita et al., 2009). Because the RNase and CCCH zinc finger domains 
are highly conserved between C30F12.1 and Zc3h12a/MCPIP1/Regnase-1 (Fig. S2 and 3A), we named 
C30F12.1 as REGE-1 (REGnasE-1). To verify that C. elegans lose fat upon rege-1 RNAi, we stained the 
animals with Oil Red O (ORO) and enzymatically determined the levels of triglycerides (TAGs), which are 
the main storage form of lipids. By both approaches, we confirmed that the fat levels were reduced (Fig. 
2A-B). Additionally, we examined lipid droplets in live animals by Coherent Anti‐Stokes Raman 
Spectroscopy (CARS) and found that REGE-1–depleted animals had substantially reduced numbers of lipid 
droplets (Fig. 2C). Because germline plays an important role in fat homeostasis (Hansen et al., 2013), REGE-
1 could affect body fat by functioning in the germline. However, the loss of fat also occurred in REGE-1–
depleted, germline-less (glp-1) animals (Fig. 2D), suggesting that, to promote fat accumulation, REGE-1 
functions in the soma.  
REGE-1 is a putative RNase primarily expressed in the intestine 
To study REGE-1 in more detail, we generated a deletion allele, rege-1(rrr13), predicted to cause a severe 
truncation of the protein (Fig. 3A). Consistent with the RNAi-mediated depletion, rege-1(rrr13) animals 
were viable but displayed reduced fat (Fig. 3B). We also observed that they developed somewhat slower 
than wild type (Fig. S3). Both of these phenotypes were rescued by a single copy-integrated, GFP-tagged 
REGE-1, expressed under the control of endogenous promoter and 3’UTR (Figs. 3B and S3). This REGE-
1::GFP was mostly expressed in the intestinal cells adjacent to the pharynx (Fig. 3C), suggesting that REGE-
1 functions in the intestine – the primary fat-storing organ of C. elegans (Srinivasan, 2014; Watts, 2009). 
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Mammalian Regnase-1 is a cytoplasmic RNase that, by an internal cleavage, induces the degradation of 
specific mRNA targets (Iwasaki et al., 2011; Matsushita et al., 2009; Xu et al., 2012). Investigating the 
putative RNase domain of REGE-1, we noticed that the residues critical for the RNase activity of Regnase-
1 are conserved in REGE-1 (Figs. S2 and 3D), suggesting that REGE-1 may also function as an RNase.  
REGE-1 promotes body fat through the transcription factor ETS-4 
Assuming that REGE-1 functions similarly to Regnase-1, depleting REGE-1 would be expected to primarily 
affect the levels of mature but not nascent transcripts. It has recently been shown that comparing exonic 
and intronic expression across conditions (Exon-intron-split analysis, EISA) can be used to quantify the 
levels of nascent and mature transcripts in standard RNA-seq experiments (Gaidatzis et al., 2015). We 
thus performed RNA-seq on animals subjected to control or rege-1 RNAi and compared changes in the 
levels of nascent RNAs (Δintron) to the changes in mRNAs (Δexon). Although most of the observed changes 
in mRNA levels could be explained by differential transcription, we observed a small group of transcripts 
that were affected mainly at the level of mRNA, the most extreme example being ets-4 mRNA (Figs. 4A-B, 
S4A and Tables S1-2). Consistent with REGE-1–mediated regulation, we found, by western blot, that the 
GFP and FLAG-tagged ETS-4 protein was more abundant upon rege-1 RNAi (Fig. 4C). Importantly, we did 
not detect any obvious expression of this protein in wild-type animals, but observed its strong expression 
in the intestine nuclei upon rege-1 knockdown (Fig. 4C), suggesting that REGE-1 and ETS-4 function in the 
same tissue. ETS-4 belongs to the ETS-domain family of transcription factors (Sharrocks, 2001). Prior to 
this work, ETS-4 was studied in the context of aging and ETS-4–regulated genes were reported 
(Thyagarajan et al., 2010). Interestingly, we found that transcripts reportedly activated by ETS-4 were 
enriched among the transcripts upregulated in REGE-1–depleted animals (data not shown). This suggested 
the possibility that the increased expression of ETS-4 may be largely responsible for the changes in gene 
expression observed in rege-1 animals. To test this, we compared changes in transcript levels between 
rege-1(rrr13) and rege-1(rrr13); ets-4(RNAi) animals, to the changes in transcript levels between animals 
subjected to rege-1 or mock RNAi. Impressively, we found that the majority of changes in gene expression 
observed in the absence of REGE-1 were reversed by the additional depletion of ETS-4 (Fig. 4D and Table 
3), suggesting that ETS-4 is the major effector of REGE-1. If so, the depletion of ETS-4 would be expected 
to rescue the phenotypes observed in rege-1(rrr13) animals. Indeed, we found that the RNAi-mediated 
depletion of ets-4 mRNA (but not of other putative targets marked in red in Fig. 4A), restored both fat and 
developmental timing in rege-1(rrr13) animals to the wild-type values (Figs. 4E and S4B). By examining 
gene ontology terms associated with transcripts induced by ETS-4 in rege-1(rrr13) animals (the transcripts 
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marked in red in Fig. 4D), we found two major classes of genes: genes implicated in lipid metabolism and 
responses to pathogens (Fig. S5A and Table S4). While the former category includes key genes functioning 
in the fatty acid degradation pathway (Fig. S5B), the latter category contains many genes induced upon 
infection with bacterial or fungal pathogens (Fig. S5C) (Engelmann et al., 2011). 
REGE-1 regulates ETS-4 posttranscriptionally through the 3’UTR 
Regnase-1 is an RNA-binding protein (RBP) that targets 3`UTRs of specific mammalian mRNAs. To test if 
REGE-1 regulates ETS-4 expression by targeting the 3’UTR of ets-4 mRNA, we produced strains carrying a 
single copy-integrated ets-4::gfp, expressed from the endogenous ets-4 promoter and fused to either 
endogenous (ets-4), or unregulated (unc-54) 3’UTR. We found that the depletion of REGE-1 caused 
increased expression of ETS-4::GFP only when this expression was controlled by the ets-4 3’UTR (Fig. 5A). 
Thus, ets-4 3’UTR is required for the REGE-1–mediated regulation. To examine this further, we produced 
a strain expressing a reporter GFP (fused to H2B to accumulate signal in the nucleus, facilitating 
quantification) from a ubiquitous promoter (dpy-30) under the control of the ets-4 3`UTR. In wild-type 
animals, we observed the expression of this reporter in various tissues and across development (reflecting 
promoter activity, data not shown) but not in the gut nuclei (Fig. 5B). In contrast, in rege-1(rrr13) mutants, 
this reporter GFP was additionally expressed in the gut nuclei (Fig. 5B). Thus, the ets-4 3’UTR is not only 
required but also sufficient for REGE-1–mediated regulation of ETS-4 expression. To examine which part 
of the ets-4 3’UTR is targeted by REGE-1, we produced strains expressing the reporter GFP under the 
control of truncated variants of the ets-4 3’UTR. We found that the fragment spanning the first one-third 
of the 3’UTR (fragment F1, 357 nt) was sufficient for the repression of the reporter GFP in the gut nuclei 
and this repression was alleviated upon rege-1 RNAi (Fig. 5C). Examining this fragment more closely, we 
noticed a stretch of homology between the corresponding sequences from other nematode species (Fig. 
S6). To test the functional significance of this fragment (fragment F1S, 115 nt), we “transplanted” it into 
the otherwise unregulated unc-54 3’UTR. We found that this transplantation rendered the unc-54 3’UTR 
sensitive to the regulation by REGE-1 (Fig. 5D), suggesting that the RNA features required for REGE-1–
mediated regulation are contained within the F1S fragment.  
REGE-1 induces an endonucleolytic cleavage within the ets-4 3’UTR 
To test if the putative RNase activity of REGE-1 is important for the regulation of ets-4 mRNA, we mutated, 
by genome editing, conserved amino acids (indicated in Fig. 3D) in the RNase domain of the endogenous 
REGE-1 (generating the rrr21 allele of rege-1). Expectedly, mutating these residues (D231N, D313A, D314A 
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and D332A) resulted in increased levels of ets-4 mRNA (Fig. 6A). If REGE-1 is indeed an RNase, its 
association with ets-4 mRNA is expected to be short-lived. To examine this putative association, we used 
GFP-tagged and RNase domain-mutated REGE-1 (corresponding to the rrr21 allele). By 
immunoprecipitating this REGE-1 variant, followed by RT-qPCR–based detection of associated transcripts, 
we observed that, indeed, REGE-1 associated with ets-4 mRNA (Fig. 6B). Based on the homology with 
Regnase-1 and the above experiments, REGE-1 is expected to induce an endonucleolytic cleavage within 
the F1S region of ets-4 3’UTR. Initially, we tested this by incubating immunoprecipitates of GFP-tagged, 
wild-type and RNase domain-mutated REGE-1 with in vitro-produced RNA, corresponding to the fragment 
F1S. We observed that the incubation with the wild-type, but not the RNase domain-mutated, REGE-1 
resulted in the degradation of the F1S RNA, but had no effect on unrelated RNA (100 nt of unc-54 3`UTR) 
(Fig. 6C). Finally, although detecting mRNA cleavage intermediates can be difficult, we used a modified 
5’RACE approach to amplify the 3’-terminal cleavage intermediates of ets-4 mRNA. Rewardingly, this 
approach revealed that REGE-1 cleaves ets-4 mRNA within the F1S fragment of its 3’UTR (Fig. 6D). 
REGE-1 and ETS-4 may form a dynamic, auto-regulatory module  
One advantage of posttranscriptional gene regulation is its speed and reversibility. Thus, the REGE-1/ETS-
4 axis is potentially well suited to dynamically control ETS-4 levels. To test the dynamics of ETS-4 
expression, we examined ets-4 mRNA levels during starvation, which was followed by re-feeding. During 
starvation, ets-4 mRNA levels remained low for several days, increasing somewhat on the sixth day (Fig. 
7A). In contrast, upon re-feeding, ets-4 levels were strongly increased. This increase was, however, 
transient, as the levels of ets-4 were back to the pre-starvation values only one day after re-feeding (Fig. 
7A). With the changing levels of ets-4 mRNA, we expected to see the reciprocal changes in the levels of 
rege-1 mRNA. However, to our surprise, we observed similar, rather than opposite, changes of rege-1 and 
ets-4 mRNAs (Fig. 7A), suggesting their co-regulation. To test this further, we asked whether ETS-4 affects 
the levels of rege-1 mRNA. Indeed, depleting ETS-4 resulted in reduced expression of rege-1 (Fig. 7B). We 
observed this effect also using a GFP reporter, driven from the rege-1 promoter and under control of 
unregulated (unc-54) 3’ UTR (Fig. 7C), suggesting that ETS-4 induces (directly or indirectly) the 
transcription of rege-1. Thus, our findings suggest that REGE-1 and ETS-4 form an auto-regulatory module, 
which, upon an environmental change, is capable of rapidly adjusting its transcriptional output by altering 




We describe here a previously uncharacterized RNase, REGE-1, involved in the regulation of body fat. The 
mammalian Regnase-1 binds mRNAs by recognizing structured RNA, reportedly with the help of a distinct 
RBP, Roquin (Jeltsch et al., 2014). However, Regnase-1 and Roquin have been recently suggested to 
function in distinct subcellular compartments and by different molecular mechanisms (Mino et al., 2015). 
Moreover, in addition to the RNase and zinc finger domains, Regnase-1–like proteins contain two 
additional domains, of which one has been recently reported to contribute, at least in vitro, to the RNase 
activity of Regnase-1 (Yokogawa et al., 2016). Thus, the problems of how exactly Regnase-1–like proteins 
achieve specificity for selected mRNA targets and whether additional mechanisms contribute to mRNA 
regulation are only partly understood. Nevertheless, our results suggest that degradation, induced by an 
endocucleolytic cleavage, is the most plausible mechanism by which REGE-1 controls ets-4 mRNA.  
While REGE-1 degrades ets-4 mRNA, ETS-4 stimulates (directly or indirectly) the transcription of rege-1. 
Such an auto-regulatory RNase/transcription factor module is well suited to a rapid and reversible 
regulation of gene expression. We hypothesize that, coupled to the positive transcriptional feedback, 
REGE-1–mediated degradation is more efficient at buffering changes in ETS-4 levels. Thus, upon an 
environmental cue, including but perhaps not limited to nutrient abundance, the reciprocal regulation of 
REGE-1 and ETS-4 might ensure a rapid but controlled change in the transcriptional output of ETS-4, 
eliciting desired metabolic remodeling (Fig. 7D). However, proving this model will require quantitative 
measurements of both ETS-4 levels and ETS-4–induced transcription, upon manipulating regulatory 
elements in the rege-1 promoter and ets-4 3’UTR. Also, whether a particular environmental cue affects 
the module by primarily altering (levels or activity of) REGE-1 and/or ETS-4 will need to be established. 
Finally, how precisely increased levels of ETS-4 stimulate fat loss remains an exciting problem for the 
future, with potential implications for obesity research. Our preliminary observations suggest that 
increased expression of ETS-4 does not alter feeding behavior, as monitored by pharyngeal pumping of 
rege-1 mutants (our unpublished observation). Therefore, the loss of fat is unlikely caused by reduced 
food consumption. Interestingly, upon re-feeding (following long-term fasting), when the intestine is 
challenged with increased nutrient uptake and utilization, we observed a rapid upregulation of the REGE-
1/ETS-4 module, possibly indicating a role for the module in accelerating food utilization. The observed 
induction of lipid genes by ETS-4, including genes in the fatty acid degradation pathway, is consistent with 
this hypothesis. Other scenarios are, however, possible. Whether the mammalian Regnase-1 impacts fat 
metabolism remains to be determined. In cultured adipocytes, where this possibility was addressed, the 
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reported results are contradictory (Lipert et al., 2014; Younce et al., 2009). In contrast, in innate immune 
cells, Regnase-1 is well established to inhibit pro-inflammatory cytokines (Iwasaki et al., 2011; Matsushita 
et al., 2009), which, in turn, can stimulate adipocytes to lose fat (Gregor and Hotamisligil, 2011; Guilherme 
et al., 2008). Curiously, through ETS-4, REGE-1 regulates expression of many nematode defense genes, 
suggesting a conserved function of Regnase-1–like proteins in innate immunity. Although ETS-4 may 
control lipid and defense genes separately, perhaps depending on a particular environmental cue, it is 
possible that ETS-4–dependent fat loss is linked to an inflammatory response. If, so, dissecting the 
underlying mechanism could provide important insights into the well-known, though insufficiently 
understood, connection between inflammation and lipid metabolism.  
 
Figure 1.  
A. Genome-wide RNAi screen for cold sensitivity uncovers a conserved RNase as a factor promoting 
accumulation of body fat.  A. Schematic description of the genome-wide RNAi screen for cold sensitivity. 
Only those RNAi clones that induced death following the incubation at 4 °C, but not at 20 ºC, were 
investigated further.  B. Factors identified in the cold-sensitivity screen. In bold: factors whose depletion 
results in “pale” animals, suggesting reduced fat levels. This group includes a putative RNase, C30F12.1. 






Figure 2. REGE-1 promotes fat accumulation under normal growth conditions.  
A. Left: DIC color micrographs of animals, subjected to control (mock) or rege-1 RNAi, stained with the 
lipophilic dye Oil Red O (ORO) to reveal fat. Size bar: 50 μm, Right: quantification of changes in the ORO 
staining. 20-25 animals were measured per condition. Data presented as mean; error bars, here and in all 
the subsequent graphs, represent SEM.  B. Change in triacylglycerol (TAG) levels upon rege-1 RNAi.  C. 
Size and numbers of lipid droplets quantified by CARS in control and rege-1 RNAi-ed animals.  D. Change 
in fat upon rege-1 RNAi, in germline-less glp-1(e2141) animals, determined by the ORO staining. 10-15 





Figure 3.  REGE-1 is a putative RNase expressed in the intestine.  
A. Schematic view of Regnase-1/Zc3h12a/MCPIP1 and REGE-1 proteins, with the conserved domains 
indicated. The deletion allele of rege-1, rege-1(rrr13), results in a truncated protein missing the RNase 
domain.  B. The fat loss phenotype of animals subjected to rege-1 RNAi is also observed in rege-1(rrr13) 
mutants, and is rescued by a transgenic GFP-tagged REGE-1. Fat levels were quantified with the ORO 
staining. 15-20 animals were measured per genotype. C. Partial view of representative live animals, either 
not (upper animal) or expressing (lower animal) the rescuing REGE-1::GFP. In order to reduce gut-specific 
autofluorescence, the animals carried the glo-1(zu391) mutation (Hermann et al., 2005). The pharynx and 
intestines are outlined, arrowheads point to the REGE-1::GFP-expressing intestinal cells adjacent to the 
pharynx. Scale bar: 50 μm.  D. Homology model of the C. elegans REGE-1 RNase domain (surface 
representation), in two orientations, rotated around a vertical axis by 180°. Highly conserved residues 
computed by ConSurf (Glaser et al., 2003) are colored in red and orange (ConSurf color grades 9 and 8). 
Predicted active site (asterisk) and residues required for the RNase activity in the mammalian proteins are 
indicated. The numbers represent amino acid numbers in the C. elegans REGE-1 or, in parentheses, the 




Figure 4.  ETS-4 is the key effector of REGE-1.   
A. Plot comparing changes in the intronic (x = Δintron) versus exonic (y = Δexon) RNA-seq reads (reflecting 
changes in nascent versus mature transcripts, respectively) upon rege-1 RNAi. The Pearson correlation of 
r = 0.61 suggests that a substantial part of the observed changes in mRNAs may be explained by 
differential transcription. Red: putative REGE-1 targets that predominantly change (more than two fold) 
in the exonic (mature mRNA), but not the intronic (nascent RNA), reads.  B. RNA-seq read coverage at the 
genomic ets-4 locus, from animals subjected to either control (blue) or rege-1 (orange) RNAi. Exons 
are represented by thick and introns by thin lines. The arrow indicates an annotated ncRNA. The samples 
were normalized for read depth and two replicate experiments were combined to increase the coverage. 
Note the increase in the exonic (but not intronic) reads upon the depletion of REGE-1. Changes in the 
exonic and intronic reads are quantified in Fig. S4A.  C. Top: western blot of extracts from animals 
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expressing (+) or not (-) tagged ETS-4 (ETS-4::GFP::FLAG), which were subjected to mock or rege-1 RNAi. 
The abundance of ETS-4::GFP::FLAG (for brevity ETS-4), detected with anti-GFP antibody, increased upon 
rege-1 RNAi. Actin was a loading control. Bottom: partial view of live animals, subjected to mock or rege-
1 RNAi, with outlined intestines, expressing ETS-4::GFP::FLAG, visualized by the GFP fluorescence. 
Arrowheads point to the gut nuclei in a representative rege-1 RNAi-ed animal, all of which contain 
increased levels of ETS-4::GFP::FLAG. Scale bar: 20 μm.  D. Plot comparing changes in transcript levels 
upon rege-1 RNAi on otherwise wild-type animals (x) versus ets-4 RNAi on rege-1 mutant animals (y). 
Transcripts that were induced two fold by ETS-4 in rege-1 animals are marked in red.  E. Upper panel: DIC 
color micrographs of representative wild-type and rege-1(rrr13) animals, subjected to either mock or ets-
4 RNAi, and stained by ORO to visualize fat. Depleting ETS-4 restored fat in rege-1 animals to the wild-
type levels. 15-20 animals were measured per condition. Scale bar: 50 μm. Lower panel: the corresponding 




Figure 5.  REGE-1 controls ETS-4 levels posttranscriptionally.   
A. Left: partial view of live animals, with outlined intestines, expressing ETS-4::GFP from the endogenous 
ets-4 promoter and under the control of ets-4 3’UTR, subjected to either mock or rege-1 RNAi. Arrowheads 
point to the gut nuclei expressing ETS-4::GFP. Scale bar: 20 μm. Right: the corresponding quantification of 
changes in the GFP intensity, including in the control animals expressing ETS-4::GFP under the control of 
unregulated unc-54 3’UTR.  The ets-4, but not unc-54, 3’UTR rendered the expression of ETS-4::GFP 
sensitive to REGE-1. Between 5-10 nuclei per animal, in at least 5 animals per condition, were analyzed.  
Error bars here and in subsequent panels represent SEM.  B. Left: partial view of live, wild-type or rege-
1(rrr13), animals, with outlined intestines, expressing GFP::H2B reporter from a ubiquitous promoter 
(dpy-30) under the control of ets-4 3’UTR. Ovals in B-D indicate the positions of gut nuclei not expressing 
the reporter GFP in control animals. Arrowheads point to the gut nuclei expressing the reporter GFP in 
rege-1 mutant (B) or rege-1 RNAi-ed (C-D) animals. Scale bar: 50 μm. Right: the corresponding 
quantification of changes in the GFP intensity. Between 5-10 nuclei per animal, in at least 5 animals per 
condition, were analyzed.  C. Top: schematic representation of the ets-4 3’UTR and three tested fragments 
(F1-3). Below: partial view of representative live, wild-type animals, with outlined intestines, expressing 
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the GFP::H2B reporter under the control of truncated ets-4 3’UTRs. The animals were subjected to either 
mock or rege-1 RNAi, as indicated. Only the F1 fragment of ets-4 3’UTR caused repression of the GFP 
reporter. This repression was alleviated upon rege-1 RNAi. Scale bar: 25 μm.  D. Top: schematic 
representation of the F1 fragment of the ets-4 3’UTR and the shorter F1S fragment that was 
“transplanted” into an otherwise unregulated 3’UTR (unc-54; the fragment was inserted between bp 164 
and 165 of the 3`UTR). Below, left: partial view of live, wild-type animals, with outlined intestines, 
expressing the GFP::H2B reporter under the control of the modified unc-54 3’UTR (containing the F1S 
fragment of ets-4 3’UTR). The animals were subjected to either mock or rege-1 RNAi, as indicated. 
Insertion of the F1S fragment into the unc-54 3’UTR caused repression of the GFP reporter. This repression 
was alleviated upon rege-1 RNAi. Scale bar: 25 μm. The corresponding quantification of changes in the 







Figure 6.  REGE-1 induces an endonucleolytic cleavage within the ets-4 3’UTR.   
A. The levels of ets-4 and rege-1 mRNAs were measured, by RT-qPCR, in animals carrying either wild-type 
or mutated (RNase mut) alleles of rege-1. The RNase mut allele, rege-1 (rrr21), was produced by changing 
four conserved residues in the RNase domain of REGE-1 (D231N, D313A, D314A and D332A; see Fig. 3D). 
Mutating these residues increased the levels of ets-4 mRNA (left); this increase was not due to a lower 
expression of rege-1 (right). The mRNA levels were normalized to the levels of act-1 (actin) mRNA. Error 
bars here and in subsequent panels represent SEM.  B. Extracts of wild-type animals, which either did not 
express GFP-tagged REGE-1, or expressed wild-type or the RNase mut GFP-tagged REGE-1, were subjected 
to immunoprecipitation (IP) using anti-GFP antibodies. Left: western blot of the IPs, showing that the 
RNase mut REGE-1::GFP was not expressed at a higher level than the wild-type. REGE-1::GFP was detected 
with REGE-1 antibody. Right: quantification of the indicated mRNAs, by RT-qPCR, in the IPs. As indicated 
by the enrichment of ets-4 mRNA in the RNase mut REGE-1::GFP IP, REGE-1 associates with the ets-4 
mRNA.  C. Immunoprecipitates, on beads, prepared as above, were incubated with labeled RNAs 
corresponding to either the F1S fragment of ets-4 or a fragment of an unregulated (unc-54) 3’UTR. Only 
wild-type REGE-1 induced the degradation of ets-4 but not unc-54 RNA.  D. A modified 5’ RACE was 
performed to identify a 3’-terminal cleavage product of REGE-1 deriving from the ets-4 mRNA. Shown is a 
partial sequence of F1S (beginning with the nt 89 of the ets-4 3’UTR, indicated by the star in Fig. S6) and 
sequences of two, independently amplified, 3’-terminal cleavage intermediates. Dotted lines represent 




Figure 7.  REGE-1 and ETS-4 form an auto-regulatory module.   
A. Left: the levels of ets-4 mRNA were measured, at indicated time points, by RT-qPCR, in wild-type 
animals subjected to starvation for 6 days, which was followed by re-feeding for 1 day. Right: the 
corresponding changes in the levels of rege-1 mRNA. The mRNA levels, here and in B, were normalized to 
the levels of act-1 mRNA. Error bars here and in subsequent panels represent SEM. B. The levels of rege-
1 mRNAs were measured, by RT-qPCR, in animals subjected to either control or ets-4 RNAi (left), and in 
wild-type or ets-4(rrr16) mutants (right).  C. Left: shown are representative fluorescent micrographs of 
intestines (outlined), expressing GFP::H2B reporter from the rege-1 promoter, under the control of 
unregulated (unc-54) 3’UTR. The promoter was mostly induced in the first two pairs of intestinal cells 
(arrowheads). Upon ets-4 RNAi, this expression was reduced. Scale bar: 20 μm. Right: the corresponding 
quantification of changes in the GFP intensity. Nuclei from the first two pairs of the intestinal cells, in 5 
animals, were analyzed.  D. A model for the REGE-1/ETS-4–mediated control of body fat. An 
environmental change, such as nutrient availability, is transmitted, by yet unknown mechanism(s), to alter 
the level of ETS-4 and/or REGE-1. Because REGE-1 inhibits ETS-4 (by degrading ets-4 mRNA) and, 
conversely, ETS-4 promotes REGE-1 (by inducing, directly or indirectly, rege-1 transcription), a change in 
either protein eventually alters the abundance of ETS-4. This leads to altered expression of ETS-4 target 
genes, including fat catabolic and innate immunity genes, consequently leading to either gain (when ETS-
4 is low) or loss (when ETS-4 is high) of fat. 
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EXPERIMENTAL PROCEDURES  
General animal handling and RNAi 
Unless stated otherwise, animals were grown at 20 °C as described before (Brenner, 1974). RNAi of 
individual genes was performed by feeding animals with bacteria expressing dsRNA, beginning from the 
L1 or L4 larval stage.  
Genome-wide RNAi screen 
For the genome-wide RNAi screen, we used the Ahringer feeding library. The library was replicated in the 
96-well format. Overnight cultures of this stock, supplemented with 2 mM IPTG, were used to seed 24-
well plates. 10-15 staged L4 N2 animals were transferred per well. Knockdown was conducted for about 
40 hours and, after inspection for death or sterile animals, the animals were adapted at 10 °C for 2 hours 
and then incubated at 4 °C for 3 days. Afterwards, the animals were incubated at 20 °C for several hours 
to recover. Dead animals were scored and clones with more than 4 dead animals were re-tested at least 
three times. The RNAi clones were sequenced.   
Oil red O (ORO) staining, image processing and quantification 
To visualize overall fat, ORO staining was performed essentially as described before (O'Rourke et al., 
2009). All image-processing steps were done with the Fiji/imageJ software (Schindelin et al., 2012). RGB 
images were stitched with the Grid/Collection stitching plugin (Preibisch et al., 2009) and corrected for 
white balance by equalizing background mean values in the red, green and blue channels. After conversion 
from RGB to HSB color space and background subtraction, red pixels were selected by thresholding the 
“H” (Hue) channel (only pixels with a Hue value between 0 and 7 are kept). A binary mask was created 
with the Saturation channel and applied to the thresholded image. After conversion to 32-bit, zero pixel 
values were replaced by NaN. The integrated density of all remaining pixels was used as an index of the 
amount of red staining in the animals (Fiji/ImageJ macro available upon request). 
Triglyceride (TAG) assay 
Total triglyceride content was assayed essentially as before (Martorell et al., 2012), using the Triglyceride 
Quantification Colorimeric/Fluoromeric Kit from Biovision (Cat. no. K622-100). Animals were synchronized 
by hypochlorite treatment and grown on OP50 plates at 20 °C to the L4 stage. RNAi knockdown was 
performed for 48 h. After collecting 50 animals, and two washes in PBS, the animals were pelleted and re-
suspended in 300 μl TAG buffer. Sonication was conducted with a Branson Digital Sonifier five times at 10 
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% power for 30 s. Worm debris were excluded by centrifugation and supernatant heated twice to 95 °C 
for 5 minutes. 50 μl and 25 μl of the supernatant were used to assess TAG content according to the 
protocol provided with the kit. Measurements were done in biological triplicates and technical duplicates. 
Coherent Anti-Stokes Raman Spectroscopy (CARS) 
Animals were grown at 20 °C from L1 to L4 stage and then transferred to RNAi plates. After 48 hours, 
animals were mounted on a slide with a drop of 2 % agarose with 20 mM levamisol. The animals were 
then examined by CARS microscopy on a Leica TCS SP8 system with a CARS laser picoEmerald (OPO, > 600 
mW at 780 nm to 940 nm, pulse width 5 to 6 ps, 80 MHz; Pump, > 750 mW at 1064 nm, pulse length 7 ps, 
80 MHz) and with LAS AF software. The lasers were adapted to the symmetrical C-H stretch range by 
tuning the pump beam to 816.4 nm while keeping the Stokes beam constant at 1064.6 nm. The output of 
both lasers was set to 1.3 W and the scan speed to 400 Hz. An image with the dimensions 145.31 µm x 
145.31 µm (968 pixels x 968 pixels) and stacks of approximately 30-50 sections with a step size of 
approximately 0.6 µm were collected. Only signals from epi-CARS (E-CARS) and epi-SHG (E-SHG) detectors 
were collected. Animals were imaged just below the pharynx with one stack per animal and approximately 
10 animals per conditions. Each experiment was repeated three times. The number and size of lipid 
droplets in each stack were examined with the Fiji software package with the Plugin DropletFinder. 
Homology modeling of C. elegans REGE-1 RNase domain 
The protein sequence of the REGE-1 RNase domain (Uniprot Q95YE2) was submitted to the HHPRED server 
for homology detection and structure prediction (Söding et al., 2005) in a search against known structures 
in the Protein Data Bank (www.rcsb.org). The structure of the human Regnase-1/MCPIP1 RNase domain 
(PDB 3V33; (Xu et al., 2012)) was the top hit  (Score=360.7, E-value = 2.9e-57, 60% sequence identity) and 
its HHPRED alignment with the REGE-1 RNase domain was used for calculating a homology model 
encompassing residues 224-384 via the HHPRED MODELLER pipeline. Structural figures were prepared 
with PyMOL (www.pymol.org). 
Mapping of conservation onto the REGE-1 RNase domain homology model 
The homology model of REGE-1 RNase domain (residues 224-384) was uploaded to the ConSurf server 
(Glaser et al., 2003) using default parameters for mapping of conserved residues onto the structural 
model. The PSI-BLAST search for homologous sequences was done against the UniProt database and 
position specific conservation scores were calculated on 100 unique sequences. 
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Developmental timing assay 
Animals were synchronized by bleaching and allowed to hatch in M9 buffer overnight. Around 200 staged 
L1 animals of each genotype were allowed to develop into L4s on RNAi knockdown and control plates. 
Picking L4s, the ratio of young adults/L4 (at least 35 animals per time point) was assessed every 2-3 h until 
all animals, of the respective strains, had reached adulthood. Development of vulva, alae and gonad were 
used to judge the developmental stage. 
RNA extraction, RNA-seq and genomic data 
Frozen pellets of about 6000 staged, young adults were subjected to RNA extraction with Trizol as 
described before (Arnold et al., 2014). Subsequently, RNA was depleted of rRNA using the Ribo-ZeroTM 
Magnetic kit (MRZ11124C) from epicenter and column purified with the RNA Cleanup & ConcentratorTM 
from Zymo research. Quality of RNA was monitored by Bioanalyzer RNA Pico chip. Library was prepared 
using ScriptSeqTM v2 RNA-Seq Library Preparation Kit (Epicentre). 
Gene expression levels (exonic) from RNA-seq data were quantified as described previously (Hendriks et 
al., 2014). After normalization for library size, log2 expression levels were calculated after adding a 
pseudocount of 8 (y=log2(x+8)). The rege-1 and ets-4 RNAi experiments were normalized separately. 
Intronic expression levels were quantified as previously described (Gaidatzis et al., 2015). Exon-intron-
split analysis (EISA) was performed for a subset of genes (n = 3093) that showed an average expression 
level (considering all samples) of at least 4.5 on the exonic as well as on the intronic level. Genes (n = 283) 
both up-regulated upon rege-1 RNAi and down-regulated upon ets-4 RNAi were subjected to GO 
overrepresentation analysis using PANTHER classification system (Mi et al., 2005), with default setting. 
The genomic data has been deposited at the Gene Expression omnibus (GEO). Accession number: 
GSE75163. Also see Tables S1-3. 
RT qPCR 
RNA for RT-qPCR was extracted as described above. 300 ng of RNA was used for reverse transcription 
utilizing the QuantiTect Reverse Transcription Kit (Quiagen). The resulting cDNA was diluted 1:10 for 
further analysis. 5 μl of this dilution was used with equal volume of Express SYBR GreenER qPCR SuperMix 
w/ROX (Invitrogen) containing 0.2 μl of 10 mM of gen-specific primers. StepOneTM RT-PCR system 
combined with StepOneTM Software (Applied Biotechnologies) was used for analysis. The presented values 




Western blot analysis 
Western blot analysis was done as described before (Arnold et al., 2014). Primary antibodies diluted in 4 
% milk/ PBS-T:  mouse α-ACT-1 (MAB1501, Millipore) 1:2000, mouse α-GFP 1:1000 (Roche). Secondary 
antibodies: HRP coupled α–mouse from GM Healthcare, 1:4000. The REGE-1 polyclonal rabbit antibody 
was raised against the first 119 aa (SDIX), used at 1:1000.  
Generation of rege-1(rrr13) and ets-4(rrr16) alleles, GFP-tagged REGE-1 and ETS-4, and GFP reporter 
lines 
The rege-1(rrr13) and ets-4(rrr16) alleles were generated by CRISPR-Cas9 (Arribere et al., 2014; Katic et 
al., 2015). The mutations were verified by sequencing and outcrossed six times before analyzing. The ETS-
4::GFP, REGE-1::GFP and 3’UTR reporter lines were constructed by MosSCI (Frøkjaer-Jensen et al., 2008). 
In constructing the ets-4::gfp, we used the est-4 promoter sequence (2634 bp), ets-4 genomic sequence 
fused to the gfp, and the ets-4 3’UTR (938 bp). In constructing the rege-1::gfp, the promoter  sequence 
(2989 bp) was fused to rege-1 cDNA (1908 bp), gfp and rege-1 3`UTR (262 bp). To check whether the F1S 
sequence is sufficient for REGE-1–mediated regulation, we inserted it into an otherwise unregulated 
3`UTR, unc54, between bp 164 and 165. The sgRNA sequences and primers used for construct generation 
are provided in the Supplementary Materials. 
Quantification of the ets-4 3’UTR GFP reporter 
Images for quantification of GFP intensity of reporter strains were acquired with an AxioImager.Z1 
microscope (Zeiss, Jena, Germany) equipped with a 63x objective and an MRm camera (Zeiss). Signal 
intensity of a circular area of 52 pixels diameter of 5-7 gut nuclei of 5 animals per condition was measured 
in ImageJ and normalized to the background. In addition 30-35 animals per strain were visually inspected 
for GFP expression. 
Generation of point mutations in the REGE-1 RNase domain  
Four point mutations (D231N, D313A, D314A and D332A) were introduced at the endogenous locus of 
C30F12.1, by CRISPR/Cas9 genome editing performed by Knudra Transgenics. The editing was performed 
in two steps: in the first D231N and then, simultaneously, D313A, D314A and D332A. The obtained 
mutations, resulting in the rege-1(rrr21) allele, were verified by sequencing and the homozygous 




Starvation and re-feeding 
The assay was modified after (Seidel and Kimble, 2011). Animals synchronized by hypochlorite treatment 
were hatched overnight in M9 and grown to young L4 stage. They were collected, washed two times with 
M9 buffer and transferred to plates devoid of bacteria. For re-feeding, the animals were transferred to 
bacteria-seeded plates. At indicated times, RNA was extracted and processed as described earlier. 
REGE-1 IP / ets-4 RT-qPCR  
Proteins were extracted from staged young adults as described for western blot analysis. 40 µl of 
Chromotek GFP Trap_A were washed twice in EB++ (EB + RNasin 5µl/ml form Promega) and 3 mg of 
protein was added to a final volume of 1 ml. After incubation overnight on 4 °C, the beads were washed 
four times with 600 µl EB++ and RNA was extracted directly from the beads by adding 500 µl Trizol. After 
RNA extraction and subsequent qPCR analysis, fold-enrichment was calculated as following: Enrichment 
IP over input: ΔCt [normalized RIP] = Ct [RIP] – (Ct[input]-Log2(input dilution factor)); normalized to 
control/non specific(NS) IP ΔΔCt [RIP/NS] = ΔCt [normalized RIP] – Δ [normalized NS] ; Fold- enrichment: 
2^(- ΔΔCt [RIP/NS]. 
On-the-beads RNase assay 
Radioactively labeled RNAs were transcribed from PCR products. Templates for transcription were 
generated by PCR with an extended phage T3 RNA polymerase promoter 
(AATTAACCCTCACTAAAGGGAGAA) appended to the 5’ end of the 5’ primer, and gel-purified. 
Transcription was performed in 3 µl reactions containing 0.5 µl template, 1.5 µl αP32 UTP (3 µM) and 0.6 
µl 5X transcription buffer (Promega), 0.2 µl RNasin (Promega), 2.5 mM rATP, rGTP and rCTP, and 0.025 
mM rUTP (Roche) at 37 oC for 3 h. The reaction was stopped by adding 30 µl TE and the RNA was purified 
on Spehadex G-25 columns (Roche) using manufacturer’s instructions. REGE-1::GFP was 
immunoprecipitated as above. The beads were washed additionally once with RNase assay buffer (20 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl2, 2 mM DTT). RNA (105 cpm) was suspended in RNase assay 
buffer and incubated with IP beads for 15 minutes at room temperature. The tubes were centrifuged and 
supernatant was loaded on a pre-run 6% denaturing polyacrylamide gel. After electrophoresis at 200 V 




Modified 5’ RACE 
To identify the 3’-terminal cleavage product of ets-4 mRNA, we employed a modified 5’ RLM RACE 
protocol (Schmidt et al., 2015). 3-5 µg of total RNA was ligated with 0.8 µg of 5’ RNA linker 
(GUUCAGAGUUCUACAGUCCGACGAUC) in a 10 µl reaction with 5U T4 RNA ligase in 1X RNA ligase buffer 
(NEB) and 1.5 mM ATP. The ligated RNA sample was reverse transcribed with a gene specific primer for 
ets-4 and SuperscriptIII reverse transcriptase (Thermo Fischer Scientific) using manufacturer’s 
instructions. PCR was performed to obtain the cleaved product using a forward primer in 5’ RNA linker 
and ets-4 reverse primer upstream of the RT primer. PCR products were sequenced to determine the 
cleavage site.  
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Figure S1.  Characterization of cold-induced suspended animation in C. elegans and of factors required 
for cold survival 
A. Shown are fractions of alive adults at 20 °C. Prior to this, the animals were incubated for 24 hours at 
either 20 °C (control), 4 °C (cold-shocked) or at 4  °C but following a prior incubation at 10 ºC for 2 hours 
(cold-adapted). Data presented as mean, error bars represent SD.  B. Numbers of viable progeny per 
animal, based on analysis of at least 10 individual hermaphrodites. Following a 2 hours adaption at 10°C, 
the animals were incubated at 4 °C for the indicated number of days. Data presented as mean, error bars 
represent SD.  C. Life span measurement. Top: schematic explanation of the experimental setup. Red 
arrows indicate the beginning of the life span measurement (t = 0). Blue line indicates the 6 days, prior to 
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the life span measurement, that the cold-adapted animals spent at 4 ºC. Bottom: Meier-Kaplan survival 
plot representing the life span of control (black line) and cold-adapted animals (red line). Analysis was 
done in triplicates, each with around 150 animals. P-value: 0.0349.   D. ORO staining of control (20 °C) and 
cold-adapted animals that were incubated at 4 °C for the indicated number of days (d). Size bar: 50 μm. 
Quantification of the ORO changes is on the right. 5-10 animals were measured per condition. Data 
presented as mean, error bars represent SEM.  E. Survival of animals, subjected to RNAi against the 
indicated genes (summarized in Fig. 1B), was examined, in a time course-like fashion, following their 






Figure S2.  Conservation of the RNase domain of REGE-1, related to Figure 3: Sequence alignment of H. 
sapiens Regnase-1/ZC3H12A and C. elegans REGE-1, comprising RNase and CCCH zinc finger domains. The 
alignment was computed with HHPRED (Söding et al., 2005), or www. 
http://toolkit.tuebingen.mpg.de/hhpred, and used for modeling the C. elegans REGE-1 RNase domain. 
Arrowheads indicate the N- and C-termini of the human Regnase-1/MCPIP1 RNase 3D template (PDB 
3V33, (Xu et al., 2012) and the C. elegans REGE-1 RNase homology model. Shaded are identical and similar 





Figure S3. Rescue of the rege-1(rrr13) developmental delay by GFP-tagged REGE-1, related to Figure 3: 
Fraction of adults, among wild-type, rege-1(rrr13) or rege-1(rrr13) animals carrying the transgenic rege-
1::gfp, determined at the indicated times (hours past the release from the L1 larval arrest; for details see 
experimental procedures). Note that the single copy-integrated rege-1::gfp rescued the developmental 






Figure S4.  REGE-1 targets ets-4 mRNA, related to Figure 4: A. Boxplot based on exon-intron split analysis, 
which was performed for each exon and intron of the ets-4 gene. For introns shorter than 150 bp (other 
introns), mapped reads were summed before normalization with library size. Inset legend indicates the 
data points used for the boxplot from 4 experiments. The glp-1 mutation results in germline-less animals.  
B. Left: % of adults among wild-type or rege-1(rrr13) animals, subjected to either mock or ets-4 RNAi, was 
determined at the indicated times (past the release from the L1 larval arrest; for details see experimental 
procedures). At least 30 animals were analyzed per time point and condition. Right: representative 
micrographs of adults 65 h post the L1 stage. Note that depleting ETS-4 restored the wild-type size 





Figure S5.  ETS-4 induces expression of lipid metabolic and defense genes, related to Figure 4: A. Gene 
ontology terms significantly enriched among the transcripts marked in red in Fig. 4D. The two major 
classes are fat metabolism (on colored background) and innate immunity.  B. A simplified view of the fatty 
acid degradation pathway. Enzymes catalyzing the individual steps are indicated on the black background. 
In red are transcripts encoding the corresponding enzymes, which increase in abundance in rege-1(rrr13) 
animals (fold changes in parentheses). The first three steps in the pathway involve the delivery of fatty 
acyl-CoA into mitochondria. Dotted arrow collectively indicates beta-oxidation, resulting in the production 
of acyl-CoA and acetyl-CoA, which is further consumed in the citric acid cycle to produce energy.  C. The 
relation between genes up-regulated by ETS-4 (red genes in Fig. 4D) and genes up-regulated upon 
pathogenic infections (Engelmann et al., 2011). Shown are proportional Venn diagrams showing the 
overlap between ETS-4–induced genes and genes induced by bacterial (Serratia marcescens, Potorhabdus 
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luminescens, Enterococcus faecalis) and fungal (Drechmeria coniospora, Harposporium sp.) infections. D. 
coniospora infects C. elegans via cuticle and epidermis, while others are able to infect through the 




Figure S6.  The F1 fragment of ets-4 3’UTR contains a stretch of highly conserved sequence, related to 
Figures 5 and 6:  Shown is the sequence of fragment F1 (nt. 1-357), aligned to the corresponding 
sequences from other Caenorhabditis species (briggsae, remanei, brenneri and japonica). In red is the 
sequence of fragment F1S (nt. 45-159). “*” indicates the beginning of sequence shown in Fig. 6D and 
arrowhead points to the position of REGE-1–mediated cleavage. 
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Table S1. Related to Figure 4. Normalized exonic read counts (log2) from RNA-seq for mock and rege-1 
RNAi treated animals in N2 as well as in glp-1 backgrounds. 
Table S2. Related to Figure 4. Normalized intronic read counts (log2) from RNA-seq for mock and rege-1 
RNAi treated animals in N2 as well as in glp-1 backgrounds. 
Table S3.  Related to Figure 4. Normalized exonic read counts (log2) from RNA-seq for mock and ets-4 











Table S4. Related to Figure 4 and Figure S5. Genes induced by ETS-4 (highlighted in red in Fig. 4D). 
Upregulation upon pathogenic infection is indicated by a green square. Lipid or defense-related GO terms 




Supplementary Experimental Procedures 
Strains used in this study 
Strain CGC/ Ciosk lab No.  
N2 bristol N2 
glp-1(e2141) III. CF1903 
glo-1(zu391) X. JJ1271 
glo-1(zu391) X.; rrrSi411 [Prege-1::rege-1(cDNA)::gfp::rege-1 3'UTR; unc-119(+)] II. 1761 
rege-1(rrr13) I. 1657 
rege-1(rrr13) I.; rrrSi411 [Prege-1::rege-1(cDNA)::gfp::rege-1 3'UTR; unc-119(+)] II.;unc-
119(ed3)III. 1667 
wgIs509 [ets-4::ty1::egfp::3xflag ; unc-119(+)]; unc-119(tm4063) III; OP509 
rrrSi400 [Pets-4::ets-4::gfp::ets-4 3'UTR] II.; unc-119(ed3) III. 1713 
rrrSi403 [Pets-4::ets-4::gfp::unc-54 3'UTR] II.; unc-119(ed3) III. 1716 
rrrSi412 [Pdpy-30::gfp::h2b::ets-4 3'UTR; unc-119 (+)] II.;unc-119(ed3) III. 1740 
rrrSi412 [Pdpy-30::gfp::h2b::ets-4 3'UTR; unc-119 (+)] II.; rege-1(rrr13) I.; unc-119(ed3) III. 1762 
rege-1(rrr21) I. [D231N, D313A, D314A, D332A] 1790 
ets-4(rrr16) X. 1758 
rrrSi413[Pdpy-30:: gfp::h2b::ets-4 3'UTR (F1); unc-119(+)] II; unc-119(ed3) III. 1792 
rrrSi416[Pdpy-30:: gfp::h2b::ets-4 3'UTR (F2); unc-119(+)] II; unc-119(ed3) III. 1795 
rrrSi418[Pdpy-30:: gfp::h2b::ets-4 3'UTR (F3); unc-119(+)] II; unc-119(ed3) III. 1797 
rrrSi428[Pdpy-30:: gfp::h2b::unc-54 3'UTR with transplanted (F1S) of ets-4 3`UTR; unc-
119(+)] II; unc-119(ed3) III. 1844 
rrrSi431 [Prege-1::rege-1(cDNA  [D231N, D313A, D314A, D332A])::gfp::rege-1 3'UTR; unc-
119(+)] II.;unc-119(ed3) III. 1816 
rrrSi423 [Prege-1::gfp::h2b::unc54 3'UTR; unc-118(+)] II. ; glo-1(zu391) X. 1807 
 
Oligos used in this study 
Purpose Name Sequence 
Amplification of rege-1 
promoter 
CH 84 (fw) GGGGACAACTTTGTATAGAAAAGTTGATTGCAGGTTACTGTACTCCGG 
CH 83 (rv) GGGGACTGCTTTTTTGTACAAACTTGTCTTGAAATTTTGTGGTTTGG 
rege-1 gene amplification 
(cDNA) 
Reg-CDS+3UTR_fw GGGGACAAGTTTGTACAAAAAAGCAGGCTATGGATTCAACGGCTCGTGGCCA 

















ets-4 gene amplification  
ecdsF GGGGACAAGTTTGTACAAAAAAGCAGGCTATGAACGGTACTGGCTCAGTCGGTC 
ecdsR GGGGACCACTTTGTACAAGAAAGCTGGGTACAAGTTATAAGGAGGCAGGAATTTG 
ets-4 3' UTR amplification 
est-4-3UTR-F GGGGACAGCTTTCTTGTACAAAGTGGTCATCTGGCAGAAAGACAACGACGT 
est-4-3UTR-R GGGGACAACTTTGTATAATAAAGTTGAGATTATGAGACCTTTGGACTTGCACA 




egfpetsM2 CAC GTC GTT GTC TTT CTG CCA GAT GAT CAT TTG TAT AGT TCG TCC ATG CCA TGT 
egfpetsR GGGGACAACTTTGTATAATAAAGTTGAGATTATGAGACCTTTGGACTTGCA 
To fuse GFP to 3'UTR of 
unc-54 
egfpuncM1 TACACATGGCATGGACGAACTATACAAATGAGATAAGAGCTCCGCATCGGCCGCTGTCA 
egfpuncM2 TGA CAG CGG CCG ATG CGG AGC TCT TAT CTC ATT TGT ATA GTT CGT CCA TGC CAT GTG TA 
egfpuncR GGGGACAACTTTGTATAATAAAGTTGAAACAGTTATGTTTGGTATATTGGG 
sgRNA site at D231   TTGAGAGCTGTGGTTGTTGA 
sgRNA site at D231   GGATCCAAGTTTGAGAGCTG 
Repair template for 
D231N   
CACCATCCAAATACAACCCGGATCCAAGTTTGAGAGCCGTTGTAGTAAATGGATCAAATGTTGCAA
TGTTGTA 
sgRNA site at D313, 
D314, D332   TGAGAATATATCTATCGTCG 
sgRNA site at D313, 
D314, D332   CACGTGAGAATCCTGCGTGG 
Repair template for 










sgRNA used to generate           
rege-1(rrr13) 
CH 5 AATTGCAAATCTAAATGTTTGGATCCAAGTTTGAGAGCTGGTTTTAGAGCTAGAAATAGC  
CH 6 GCTATTTCTAGCTCTAAAACCAGCTCTCAAACTTGGATCCAAACATTTAGATTTGCAATT 
CH 7 AATTGCAAATCTAAATGTTTGGTGTGGATGATGACGTGGCGTTTTAGAGCTAGAAATAGC  






tbb-2 qPCR rv TGGTGAGGGATACAAGATGG 





ets-4 3' UTR F1  
amplification 
etsF1F GGGGACAGCTTTCTTGTACAAAGTGGTCATCTGGCAGAAAGACAACGACGTG 
etsF1R GGGGACAACTTTGTATAATAAAGTTGTATTGCATTACAATAAATAAATCG A 








To transplant ets-4 F1S  
into unc-54 3`UTR 
ets-4SF TCTCTTAATTTCTTTGTGGTCAATACTCTGTTTACATTTTTCAAC 
ets-4SR CTTAAAAGAAGCTAAAAAGGAGGAATATGTTCTACAACGAAC 
RACE_RT CH 191 AGTAAACAGGGGAAGGAGGC 
RACE_PCR CH 194 GTTCAGAGTTCTACAGTCCGA 
CH 192 GGTAAAGTATTTGGGAGAGAGG 




unc-54 RNA transcription 
Ets4-ReBS T3 Fw 
AATTAACCCTCACTAAAGGGAGAATCAATACTCTGTTTACATTTTTC 
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2.2 Annex I:  Phenotypical analysis of fat-loss in rege-1(rrr13) 
2.2.1 Differences in food intake cannot explain the rege-1 mutant phenotype 
Feeding is regulated in accordance to food availability and sentient state of the animals (Luedtke et al. 
2010). It represents a very complex behavior, which influences the amount of food available to the gut 
cells for processing, but does not always have an influence on the fat content of the animal (Srinivasan et 
al. 2008). To address if rege-1(rrr13) animals show any sign of altered food intake, we measured their 
pumping rate, intake of fluorescent agarose beads, and the processing of GFP-labeled bacteria. The latter 
to check if the bacteria that pass the pharyngeal muscle are properly crushed by the grinder in order to 
release their nutrients.  
Pumping rate of rege-1(rrr13) is slightly increased 
The pumping of the pharyngeal muscle is a very stereotypical behavior that can vary in its frequency, but 
is reproducible under stable in conditions. As this behavior is very stereotypical, the frequency by which 
the posterior bulb moves during the contraction/relaxation cycle can be used as an estimate of the 
number of pumping motions of the whole pharynx. We found that, on average, rege-1 mutants pump 
slightly more frequent than wild type animals (Figure 8A). This observation might reflect an attempt to 
counteract their poor nutritional status, but cannot explain why rege-1(rrr13) exhibit reduced fat content. 
Intake of fluorescent beads in rege-1(rrr13) is slightly decreased compared to wild type 
If the coordination of the pumping motion is affected, the movement of the posterior bulb might not 
reflect the intake of bacteria reliably (i.e. the animals move their posterior bulb, but release bacteria back 
into the environment). To explore this option, fluorescent agarose beads of the size of an average bacteria 
(0.5µm) where mixed with normal OP50, fed to the animals and the intake of particles was monitored by 
measuring the fluorescence in the gut. A slight reduction of fluorescent signal can be observed in rege-1 
mutants versus wild type animals on average. However, as a large population of wild type animals exhibit 
quite weak signal and we find many rege-1 mutants with high fluorescence signal, we think that alteration 
of bacteria intake between these two strains cannot explain the rege-1(rrr13) fat loss. (Figure 8B).  
rege-1(rrr13) animals have a functional grinder 
The task of the terminal bulb is to reliably crush bacteria to: i) release their nutrient content into the 
intestinal lumen and ii) kill any potentially pathogenic bacteria to reduce the possibility of infection. 
Malfunctions of the grinder impair the uptake of nutrients and render animals more susceptible to 
infection (Labrousse et al. 2000). To investigate the functionality of the grinder, we fed GFP-expressing 
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bacteria and monitored their distribution within the pharynx and the intestine. In wild type animals GFP 
locates mainly in the pharynx and weakly in the intestinal lumen, thus the bacteria are crushed sufficiently 
to release their content. In contrast, in the negative control eat-2, mutants show hardly any visible GFP in 
the pharynx (reflecting their previously reported feeding defect (Raizen, Lee, and Avery 1995)), but very 
strong GFP signal in the gut. This drastic increase of GFP reflects the insufficient grinding of microbes and 
retention of live bacteria in the intestine previously reported (So et al. 2011). In rege-1(rrr13) animals GFP 
localizes in the pharynx and is absent from the intestine (Figure 8C). Thus, we conclude that the bacteria 
are properly crushed and their interior is available to the intestinal cells of the worms.  
In summary, rege-1 mutant animals do not exhibit any change in feeding-related behavior that could 
explain their strong fat loss. Thus, further assays need to be applied to elucidate the pathway(s) involved 
in this phenotype. 
2.2.2 REGE-1 in relation to major fat regulatory pathways 
Knock-down of rege-1 leads to reduced fat in daf-2, daf-7 and tph-1 mutants 
The three major signaling pathways involved in fat metabolism in C. elegans are insulin, TGFβ and 
serotonin signaling. Functional loss of any of these pathways leads to a strong increase of stored fat in the 
animals. Interestingly, knock down of rege-1 in all tree mutant backgrounds causes a decrease of fat 
(Figure 9A-C) to a different extend. This indicates that REGE-1 acts downstream or in parallel to this 






Figure 8: Food uptake in rege-1(rrr13) is comparable to wild type. A: Pharyngeal pumping of wild type 
and rege-1(rrr13) animals. Shown is the sum of two independent biological replicates with each 8-10 
analyzed animals.  B: Fluorescent beads assay. Each dot represents a single analyzed animal. Fluorescent 
intensity was normalized to the area of the worm body. C: Representative images of animals fed with GFP-
expressing bacteria. Overlay of DIC and GFP to show localization of the bacteria. Scale bar: 50µm. 
 
Figure 9: REGE-1 acts downstream or in parallel of major fat metabolic signaling pathways. Oil red O 
quantification of RNAi-mediated knock down of rege-1 in the background of daf-7(e1372), tph-1(n4622) 
or daf-2(e1370). Changes in Oil red O intensity are normalized to the respective mock control. 8-10 
animals were quantified per condition. 
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2.3 Annex II:  Screens to identify ETS-4 targets that mediate rege-1 fat loss 
2.3.1 Targeted RNAi screen  
Accelerated fat catabolism could be one possible explanation for the fat loss in rege-1 mutants. Thus, 
knock-down of essential players of the fat pathway such as lipases and β-oxidation might reverse this 
phenotype. In order to identify genes, which are consequential for the fat-loss and developmental delay 
of rege-1 mutant animals, we performed RNAi-mediated knock down of selected targets that fall in 
distinct categories: 1. Transcripts that are likely direct targets of rege-1 as they exhibit upregulated exonic 
reads, but were unchanged intronic levels upon knock down of rege-1i highlighted in red in Figure 4A; 
among those we identified ets-4; 2. Transcripts that are upregulated upon knockdown of rege-1 and have 
assigned GO terms related to lipid and fat metabolism; 3. Transcription factors that are predicted by 
HOMER analysis (Heinz et al. 2010) to regulate genes that are upregulated upon rege-1 knock down; 4. 
Transcripts that are up-regulated upon knockdown of rege-1 and down-regulated in the rege-1(rrr13);ets-
4i double mutant (in red in Figure 4D) and have annotated GO terms related to lipid metabolism (4a) or 
innate immunity (4b) 5. Additional genes, previously reported to be important players of fat catabolism 
such as β-oxidation genes and lipases that were absent in the other categories. RNAi-mediated single gene 
knock-downs of more than 100 genes (Table 1) were conducted in rege-1(rrr13) background and animals 
were screened for increased fat and rescue of developmental delay. Only knock down of ets-4 suppresses 
these phenotypes. Hence, it is likely that a distinct combination of ets-4 targets is responsible for the fat 
loss. The reason why we were not able to identify these targets might have various reasons: 1. 
Redundancy in the fat metabolism might compensate for the loss of important fat metabolic genes and 
would make simultaneous knock down of two of more factors necessary; this would also be the case if 
multiple pathways would be affected by loss of rege-1 2. Inefficient knock down of the genes by RNAi. 
2.3.2 Random mutagenesis screen by ethyl methanesulfonate (EMS) 
To identify ets-4 targets, which are responsible for the fat-loss phenotype of rege-1(rrr13), we performed 
a random mutagenesis screen. EMS-based screens are widely and successfully used among C. elegans 
researches. Treatment with this alkalic agent leads to a chemical modification of guanine bases and causes 
them to miss-pair with an arginine; consequently introducing a heritable mutation in the next round of 
replication (Coulondre and Miller 1977; Brookes and Lawley 1961). The strain rege-1(rrr13); ets4(rrr16) 
containing a GFP tagged copy of ETS-4 to visualize ETS-4 levels, was subjected to EMS-based mutagenesis. 
Subsequently, we screened the F2 generation for a darker appearance of the gut, representing increased 
fat levels (screening scheme: Figure 10A). During two rounds of mutagenesis we screened roughly 50.000 
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haploid genomes in a semi clonal fashion and were able to recover five potential suppressors from four 
independent batches, representing independent mutations. (Figure 10B). Two (mut1 and mut4) of these 
exhibit a weak GFP signal during early larval stages and almost no GFP upon entering adult stage. Thus, 
they might represent a mutation in the transgene which alters its expression. However, as the expression 
is not completely vanished it is less likely that it is a simple loss of function allele.  Furthermore, in the 
other three mutants (mutA, mutB, mutC) the strength of the GFP signal is similar the non-mutagenized 
strain. Thus, we speculate that these represent mutations in a locus distinct from the transgene. To 
identify genes that are causal for the suppression, we will backcross these mutants to the original strain 
(rege-1(rrr13); ets4(rrr16); ets-4::GFP) and subsequently perform deep sequencing as done before 
(Tocchini et al. 2014).   Although the identity of the mutants is yet to be revealed, it is exciting to find that 





Table 1:  Candidate genes for the targeted RNAi-knock down screen.  
Numbers on yellow background refer to the categories described in section 2.3.3. 1: “Transcripts with 
changed ratio in exonic/intronic reads” are transcripts, which show an increase concerning their exonic 
reads, but unchanged levels of intronic reads upon knock down of rege-1 (highlighted in Figure 4A).  2: 
“Upregulated genes GO term lipid” contain genes that are more than two fold upregulated compared to 
the control (mock versus rege-1i) and have annotated GO terms related to lipid metabolism. 3: “TFs” are 
transcription factors predicted to bind the regulatory regions of transcripts which are upregulated in mock 
versus rege-1 RNAi. 4: Transcripts that are upregulated upon knock down of rege-1 (i.e. mock versus rege-
1i) and down-regulated upon loss of ets-4 in the background of rege-1(rrr13) (i.e. rege-1(rrr13) versus 
rege-1(rrr13);ets-4)) more than two-fold. For simplicity, only the transcriptional changes of rege-1(rrr13) 
versus rege-1(rrr13);ets-4i are shown for this category.  4a: “Upregulated genes GO term lipid” and 
4b:“Upregulated genes GO term immunity” are genes that are more than two fold upregulated compared 
to the control and have annotated GO terms related to lipid metabolism and innate immunity, 





Figure 10: Random mutagenesis screen to identify ets-4 targets that are responsible for rege-1(rrr13) 
loss of fat. A: Screening scheme. B: Representative pictures of the strain used for EMS-based screening 
rege-1(rrr13);ets-4(rrr16);ets-4::gfp exhibiting a pale phenotype and wild type (N2) animals with a dark 
gut representing the desired suppressor phenotype. Red and green arrows point to regions behind the 
pharynx and close to the tail, respectively, where changes in fat content in the animals are most visible  C: 
representative pictures of mutants obtained from the screen and indicated GFP expression. Mutant name 
and the batch number is indicated “1”= first round of screening “2”= second round of screening. mut B/2.3 
and mut C/2.3 were found in the same batch. 
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Experimental procedures of additional results 
Pumping rate 
Animals were bleached and grown to L4 stage. 20-30 L4 were picked to fresh plates and incubated 
overnight to develop into young adults. Animals were given some acclimation time under the light 
microscope (few minutes), then pumping of individual animals was recorded 3x for about 1 minute.  To 
determine the pumping rate, 15 second videos of continuous pumping were slowed down to 0.5x speed 
and movement of the terminal bulb was counted manually; the 15 sec videos were used to estimate the 
pumping rate per minute. Each video was counted three times to ensure reliability.  From each strain, 8-
10 worms were used and their pumping rate was assayed from 3 different videos (i.e. 3 different minutes); 
two biological replicates were summed.   
Beads assay 
Staged and washed L4 are pipetted into wells of a 384-well plate (15 worms/well) that contain S-basal 
with OP50 (final 6mg/ml) and acclimated overnight. Fluorescent beads (Sigma, L3280 – 1 ml) were added: 
50 µl of a 1:500 dilution in S-basal. Suspension was mixed, plate covered and incubated 15 minutes at RT. 
Animals were then transferred to a 1.5ml tube, washed twice, and immobilized with 10µl of 0.04M 
levamizol. Images were taken under 10x magnification with 50ms exposure in the red channel. Images 
were analyzed using a cell profiler file “Measuring ingested beads RFP levels with Area”. This pipe-line 
applies a threshold that eliminates the average background and normalizes to the size of the animal (area). 
Feeding of GFP bacteria 
Young adults were collected, washed two times with M9 to remove residual OP50 bacteria and placed on 
plates seeded with GFP-expressing OP50 bacteria. After incubation for 20 minutes, animals were mounted 
on agarose pads and GFP distribution was observed under 40x magnification.  
EMS-based screen 
Animals were staged by hypochlorite treatment and grown to mid L4 stage. As the used strain exhibits 
developmental asynchrony, a batch of animals that displayed about 70-80% L4 stages animals was used. 
Animals were collected, washed and using sterile glass pipettes, they were transferred to a 15 ml sterile 
plastic centrifuge tube und spun down. Supernatant was removed and animals were diluted to a total 
volume of 4ml with M9, 20µl EMS (methanesulfonic acid, ethyl ester, Sigma #M0880) was added and 
incubated for three hours on a rotator. Afterwards, the animals were washed twice in M9 and transferred 
to seeded plates. The next day P0 were bleached (in three batches) to release F1, which are grow to gravid 




3.1 Physiological changes observed in rege-1(rrr13) 
We found that the loss of rege-1 is accompanied by a transcriptional increase of fat catabolic genes, which 
might explain their decreased fat levels. However, knock down of major lipases and genes involved in β-
oxidation were not able to rescue rege-1(rrr13) fat loss.  Another reason for decreased body fat can be 
reduced intake of dietary fats. Thus, we analyzed aspects of food-intake. The alterations in pharyngeal 
pumping rate and overall uptake of fluorescent beads in rege-1(rrr13) compared to wild type animals are 
only minor and feeding of GFP-expressing bacteria indicate proper grinding of the bacteria. Hence, we 
conclude that the observed changes do not account for the strong fat loss observed in rege-1(rrr13) and 
it is very likely that sufficient amount of nutrients are available to the gut cells. However, reduction in 
number, physical damage or alterations to the surface integrity of gut microvilli can lead to impaired 
transport of the nutrients form the gut lumen into the intestinal cells. To investigate this possibility, we 
plan to perform electron microscopy (EM) to inspect the surface of the lumen on a subcellular level. 
Nutrient uptake is influenced by additional factors such as proton concentration of the intestinal cells. 
The internal intestinal pH regulated by the Na+/H+-exchanger NHX-2 and was shown to influence the 
uptake of intact peptides form the lumen into the intestinal cells (Nehrke 2003). Loss of NHX-2 leads to 
decrease of intracellular pH in these epithelia cells. This disturbs the function of the peptide transporter 
pept-1 (old name: opt-2) and consequently leads to shortage of available peptides and a pale phenotype 
(Nehrke 2003). To get an insight into nutrient transport across the apical epithelia cells of the intestine, 
fluorescently labeled fatty acids (BODIPY) can be utilized. Unfortunately, so far the quantification for this 
assay proved to be challenging and needs optimization before a definite statement can be made.  
Perturbed defecation can cause decreased retention of bacteria content in the gut and consequential lead 
to fat-loss (Sheng et al. 2015). Over the length (45 seconds on average) of one cycle, three distinct muscle 
contractions (pBocs aBocs and Exps (Thomas 1990)) can be observed and the presence of this district 
motions as well as their frequency will be assessed in wild type and rege-1(rrr13). 
So far, we have not tested the possibility that the mechanisms involved in the fat loss (or reduced fat 
uptake/synthesis) might only be observable in a restricted time window. For example, upregulation of β-
oxidation reduces overall body fat, but as soon as the stored fat is utilized by the animals, a steady state 
of lipid degradation would maintain this low levels of fat. Hence, time course experiments in which a 
decrease of rege-1 or increase of ets-4 is induced and the gradual decline of fat stores are monitored while 
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examining the dynamic changes of different fat metabolic pathways and markers (e.g. major lipases such 
as ATGL-1). To address this, we are currently constructing a degron-GFP-tagged ETS-4 transgenic line. The 
fusion of the small peptide degron to a protein renders the target susceptible to auxin-induced 
degradation (Zhang, Ward, et al. 2015). This line will be crossed to rege-1(rrr13), leading to increase of 
ETS-4 protein and low body fat. Given that this approach is successful, ETS-4 levels would decline in the 
present of auxin and the increase of fat can be monitored. Vice versa, when animals are grown on auxin 
plates they presumably exhibit high fat levels and when shifted to auxin-less plates the controlled 
decrease of fat can be monitored. 
Reduction of fat synthesis and/or desaturation can be a possible cause a misbalanced fat metabolism of. 
Depending on the type fatty acid (FA), de novo synthesis accounts for about 2-20% of total FA content 
(Perez and Van Gilst 2008). This proportion seems to be negligible, considering that rege-1(rrr13) lose 
about 70% of their total body fat, however, misbalance of certain groups of fatty acids can have a 
tremendous impact on the overall fat content of the animals. For example, the double mutant of  fat-6 
and fat-7, two fatty acid desaturases, exhibits altered FA composition alongside with growth delay and 
reduction of overall body fat (Brock, Browse, and Watts 2007; Watts and Browse 2000) similar to that 
seen in rege-1(rrr13). FAT-5, a delta-9 desaturase that catalyzes the conversion of stearic acid (16:0) to 
palmitoleic acid (16:1Δ9) (Brock, Browse, and Watts 2006), is upregulated upon rege-1 knockdown and 
down regulated upon loss of ets-4 (i.e. in rege-1(rrr13);ets-4i). However, knock down of fat-5 in rege-
1(rrr13) background has no effect on its fat levels.  
 
3.2 Mediation of fat-loss by ETS-4 and its targets 
The fat-loss and developmental delay in rege-1(rrr13) animals is mediated via the transcription factor ETS-
4. Impressively, RNAi-mediated knockdown of ets-4 in rege-1(rrr13) rescues transcriptional and 
phenotypical changes alike. Thus, to identify targets of ETS-4, which mediate the observed phenotypes, 
we utilized two different screening methods. The targeted RNAi screen, during which we knocked down 
selected putative ETS-4 targets and key regulators of fat metabolism, did not reveal any suppressor. This 
may reflect redundancy of enzymes and pathways in fat metabolism or insufficient knock down by RNAi. 
To our excitement, a random mutagenesis screen revealed five potential candidates that suppress the fat-
gain in rege-1(rrr13). These mutants might fall into different categories: 1. ets-4 targets that influence fat 
content 2. Distinct genes or ets-4 alleles that influence ets-4 levels and/or activity 3. Genes, which act 
independently of the rege-1/ets-4 module to regulate fat metabolism. Two of the recovered mutants 
81 
  
show altered GFP expression compared to the non-mutagenized strain and thus, either represent 
mutations within genes that influence ets-4 levels or mutations in the ets-4:gfp transgene. These might 
be useful alleles to study upstream signaling or transcriptional and post-transcriptional regulation of ets-
4. In addition, three mutants with high expression of GFP likely represent mutations in regions district 
from the transgene. In addition it will be interesting to see if one or more mutants also rescue 
developmental delay or if these two phenotypes of rege-1(rrr13) can be genetically separated.  
 
3.3 Regulation of the ets-4/rege-1 module  
In the lab, where food is plenty and pathogens are rare, simultaneous loss of ets-4 and rege-1, to our 
knowledge, does not have negative consequences for the animals, however, this regulatory module might 
be more relevant in the animals’ natural habitat where they frequently experience food shortage and 
encounter a species rich bacterial environment. We show that ets-4 and rege-1 are transcriptionally 
activated in wild type animals upon refeeding following long-term starvation (Figure 7). This suggests that 
the ets-4/rege-1 module has an active role in food processing or bacteria clearance. Furthermore, whether 
different stimuli act first on ets-4 or rege-1 levels/activity remains elusive. We find that rege-1 acts either 
downstream or in parallel of major fat signaling pathways (Figure 9A-C). If and to what extend these 
signaling pathways might affect rege-1/ets-4 levels and/or activity is unexplored. Feeding behavior of 
animals reintroduced to food is influenced by serotonin signaling (Avery and Horvitz 1990). Thus, it will be 
interesting to see whether serotonin modulates rege-1/ets-4 levels. 
As various infection related genes are deregulated upon loss of rege-1, it is tempting to speculate that 
signaling pathways involved in innate immunity, pathogen sensing or bacteria clearance may play a role 
in the control of rege-1 and ets-4 levels. In C. elegans, at least four different pathways are involved in 
immune response: DBL-1, DAF-2/DAF-16, MAP kinase, toll-like receptors (summarized in (Ewbank 2006)). 
It will be interesting to explore whether any of this signaling pathways incluence ets-4/rege-1 levels or 
activity.  
Among the putative targets of rege-1 (transcripts upregulated on their exonic but not intronic reads upon 
knock down of rege-1; highlighted in red in Figure 4A) is clec-49. C-type lectin-like (clec) genes belong to 
a superfamily of pattern recognition receptors, which are predicted to be involved in pathogen sensing 
and often show de-regulation upon infection (Pees et al. 2016). clec-49 together with clec-39, is crucial 
for immunity against Serratia marcescens infection (Miltsch, Seeberger, and Lepenies 2014). Knock down 
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of clec-49 is does not change fat content of rege-1 mutants. Whether clec-49 is a true target of rege-1 and 
might have any influence on the susceptibility of rege-1 mutants to pathogens remains to be tested. 
However, it is intriguing to speculate that rege-1 might serve a conserved role in immunity by directly 
targeting genes involved in pathogen recognition. 
The dynamic regulation of energy metabolism and defense against pathogens are closely interconnected. 
For example, in obese patients an infiltration of adipose tissue by pro inflammatory cells drives a constant 
state of systemic low grade inflammation (reviewed in (Johnson, Milner, and Makowski 2012; Sell, Habich, 
and Eckel 2012; Wensveen et al. 2015)). This putative crosstalk becomes even more obvious in the 
bacterivore C. elegans, where energy metabolism and defense against pathogens are simultaneously 
happening in one tissue.  The ets-4/rege-1 module regulates innate immunity and lipid metabolic genes 
alike.  As the mammalian Regnase-1 degrades pro-inflammatory cytokines and might be involved in 
differentiation of pre-adipocytes (Lipert et al. 2014; Younce and Kolattukudy 2012), the function of 
Regnase-1-like proteins seems to be conserved to some extent. Certainly, loss of the Regnase-1 is 
accompanied by the occurrence of autoantibodies and is fatal postnatal. Hence, the simpler animal model 
C. elegans may be utilized to dissect downstream regulatory mechanism and help identify targets for 
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